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Abstract
An increase of metabolic risk factors is a public health threat to the well-being of the
population of Tobago; this increase is poorly documented and understood. According to a
review of evidence-based research, studies linked metabolic risk factors to the high
prevalence of obesity. However, there was a gap specific to the Tobagonian population.
This cross-sectional quantitative study assessed the evidence of metabolic risk factors to
determine whether obesity measures correlated with metabolic risk factors among a
sample from Tobago. Guided by the social-ecological theory, a self-reported survey was
used to collect primary data from 270 participants during a workplace wellness and
health-screening initiative. Descriptive statistics, chi-square, and binary logistic
regression analysis were used to analyze data. A 43.6% overall prevalence of abnormal
obesity measures was found for various metabolic risk factors. The results showed that
the prevalence of obesity correlated with diabetes (64.4%) and hypertension risk factors
(51.4%). These findings also highlighted a significance for gender specifics in which
waist circumference and body mass index had a small effect on blood pressure range ≥
130/85 mmHg. Despite acknowledged limitations for results, the findings from the
current study contribute to positive social changes by adding to the limited resources
available on the prevalence of metabolic risk factors with abnormal obesity measures
among the Tobagonian population. Implications outline the need for future research and
explain how public health practitioners and policymakers can use a holistic approach to
channel resources into health awareness and prevention initiatives.
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Chapter 1: Introduction to the Study
Obesity is a serious public health challenge that has reached an epidemic level
(Cherry et al., 2014; Samuels et al., 2014; Sheehy & Sharma, 2013; White et al., 2006).
Obesity affects many sectors of the society throughout one’s life course (Batson et al.,
2014). There is evidence showing a positive association between obesity and the
metabolic syndrome (MetS; Al-Bachir & Bakir, 2017; De Lorenzo et al., 2016; Han &
Lean, 2016; Kaur, 2014; Robbins et al., 2016). MetS includes three or more of major risk
factors: visceral obesity, hyperinsulinemia, hypercholesterolemia, and hypertension
(Pérez et al., 2008).
Although the components of MetS can be reversed, obesity increases the risk of
further health problems, such as a doubled risk for cardiovascular diseases (Han & Lean,
2016) and a fivefold chance of type 2 diabetes (T2DM; Grundy, 2008). The upsurge in
obesity is posited to be a major contributor to the development of health challenges from
MetS (Cherry et al., 2014; Nayak et al., 2016; Samuels et al., 2014; Sheehy & Sharma,
2013; White et al., 2006). An increased prevalence of obesity has been correlated to the
high incidence of T2DM, hypertension, heart disease, and hypercholesterolemia (Ashraf
et al., 2011; Chopra et al., 2013; Grundy, 2008). Scholze et al. (2010) found that two
thirds of hypertension prevalence was attributed to obesity.
In Trinidad and Tobago (T&T), these health challenges remain the leading cause
of disability and death among the population (Chadee et al., 2013; Ezenwaka et al., 2007;
Ministry of Health, Government of Trinidad and Tobago, 2017; Ramsaran & Maharaj,
2017; Roopnarinesingh et al., 2015). T&T placed fourth as having the highest number of
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fatalities from metabolic issues amongst the Caribbean and Latin America region
(Samuels et al., 2014; Sheehy & Sharma, 2013). The prevalence of obesity has escalated
within the country. The prevalence rate of diabetes rose to 13% in T&T and is projected
to increase from 60,000 to 125,000 between 2000 and 2030 (Roopnarinesingh et al.,
2015). The recognition of the underlying problems of MetS is of serious public health
concern for T&T (Ezenwaka et al., 2007; Johnson & Rodrigues, 2016; Marharaj &
Harding, 2016; Ordunez et al., 2015).
MetS creates financial constraints on a country’s health care system (Obeidat et
al., 2015). In T&T, diabetes accounted for an estimated cost of $812 million U.S. dollars
with a surplus health care expense of 329% (Roopnarinesingh et al., 2015). Similarly, the
annual health care service expenses for hypertension amounted to 3.3 billion T&T dollars
(Ministry of Health, Government of Trinidad and Tobago [MOH], 2017). G. A. Nichols
and Moler (2011) showed that T2DM and cardiovascular diseases were costlier to treat
when compared to the incidence of MetS. Being able to acknowledge and reduce the
MetS risk factors will eventually reduce the mortality rate in T&T and also minimize
avoidable health care expenses and indirect social costs (G. A. Nichols & Moler, 2011).
The present study aimed to identify the relationship between the independent
variables (waist-to-hip ratio, waist circumference, and body mass index) and the
dependent variables (abnormal blood pressure and blood glucose) as documented in the
literature (Adamu et al., 2014; Cornier et al., 2011; Czernichow et al., 2011; D’souza &
Shekar, 2015; Gregory et al., 2017; Kaplan et al., 2014; Kassi et al., 2011; Ortega et al.,
2016; Shakiba et al., 2017; Swainson et al., 2017). I addressed pertinent information
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within the clinical practice to adopt primary prevention and management of MetS risks
among the T&T population.
Chapter 1 includes a brief overview and background of the issue under
investigation. This chapter also includes the problem statement, purpose and nature of the
study, and four research questions and associated hypotheses. There is also an
introduction to the social-ecological theory (SET) that guided the study. Other focal areas
of Chapter 1 are definitions of terms, assumptions, limitations, delimitations, the
significance of the research to positive social change, and a summary of the chapter and
transition into the literature review.
Study Background
The high prevalence of obesity poses challenges for public health practitioners
because individuals are predisposed to metabolic disturbances (Choi et al., 2016;
Goossens, 2017). Both clinicians and epidemiological researchers have recognized that
obesity is a public health issue (Ashraf et al., 2011; Chopra et al., 2013; Chua et al., 2017;
Ezenwaka, et al., 2007; Grundy, 2008; Han & Lean, 2016; Johnson & Rodrigues, 2016;
Marharaj & Harding, 2016; Ordunez et al., 2015; Pan American Health Organization
[PAHO], 2017). Researchers have identified a link between obesity and metabolic risk
factors among a broad cross-cultural population, both in developed and underdeveloped
countries (Al-Bachir & Bakir, 2017; Ezenwaka et al., 2007; Guo et al., 2016; PAHO,
2017). These simultaneous effects of obesity and metabolic risk are prominent not only in
adults but also in children and adolescents (Eloi et al., 2017; Lim et al., 2015). According
to older and recent evidence, the presence of obesity increases the risk of developing
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cardiovascular problems, T2DM, and MetS, which leads to an increase in mortality and
morbidity (Al-Bachir & Bakir, 2017; Battie et al. 2016; Choi et al., 2016; Cornier et al.,
2011; Coutinho et al., 2013; Egbe et al., 2014; Elffers et al., 2017; Goh et al., 2014;
Gregory et al., 2017; Kwon et al., 2017; Oh et al., 2017; Ortega et al., 2016; Pelegrini et
al., 2014; Rahman & Adjeroh, 2015; Thomas et al., 2018).
For the current study, diagnostic criteria from the International Diabetes
Federation (IDF), the National Cholesterol Education Program Adult Treatment Panel III
(NCEP-ATP III), and the World Health Organization (WHO) were used to define
metabolic risk factors, elevated fasting blood glucose and blood pressure level, and cutoff
points for anthropometric measurements of waist circumference (WC), waist-to hip ratio
(WHR), and body mass index (BMI). Many investigators recognized the extent to which
MetS affects a population by following specific criteria cutoff points for gender and
ethnic groups set by these international agencies (Awasthi et al., 2017; Egbe et al., 2014).
Researchers investigated the competencies of several obesity measures to predict
cardiovascular and T2DM risks (Obeidat et al., 2015; Ramsaran & Maharaj, 2017).
Clinical researchers used anthropometric indices to recognize obesity prevalence and
health risks among diverse populations (R. G. de Oliveira & Guedes, 2018; Gaya et al.,
2017; Kidy et al., 2017; Murphy et al., 2014; Parks & Kim, 2012; Zhang et al., 2013).
The commonly used anthropometric measurements included WHR, BMI, and WC (R. G.
de Oliveira & Guedes, 2018; Gaya et al., 2017; Kidy et al., 2017; Murphy et al., 2014;
Parks & Kim, 2012; Zhang et al., 2013).
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The WHO sanctioned BMI as a measure to classify obesity, but some researchers
observed that BMI is unable to recognize central obesity in case of healthy weight (Kidy
et al., 2017; Olafsdottir et al., 2016; Ramsaran & Maharaj, 2017). Other health agencies
such as the IDF and NCEP ATP III preferred WC as a mandatory component in
classifying MetS, which assesses central or abdominal obesity (Kidy et al., 2017; Xu et
al., 2017). Central obesity appeared to generate a higher risk of cardio-metabolic
problems in comparison to other measures, and as a result served as a valuable marker to
support therapy (Kidy et al., 2017; Xu et al., 2017).
Apart from using anthropometric indices such as WC and WHR as predictors to
detect central obesity, imaging techniques such as magnetic resonance imaging,
computed tomography scan, or dual energy are also recognizable, but their application is
costly to identify the accumulation of visceral fat (Assaad-Khalil et al., 2015; Elio et al.,
2017). Nonetheless, these applications are reliable tools to quantify the degree of visceral
fat, which is of great clinical significance (Elio et al., 2017). The identification of central
obesity was a recognizable indication of the development of metabolic risk (AssaadKhalil et al., 2015).
Etiology of Metabolic Risks
The etiological perspectives of metabolic risks are multifactorial. Researchers
have found that genetic, metabolic, and environmental factors are linked to the
development of obesity and metabolic disturbances (Monteiro & Azevedo, 2010).
Lifestyle factors including poor dietary habits and physical inactivity are critical
attributes in the manifestation of metabolic risk (Ensenyat et al., 2017). Researchers
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observed that by incorporating healthy lifestyle behavior becomes the gold standard in
the treatment and prevention strategies of obesity and other metabolic risks (Ensenyat et
al., 2017; Olafsdottir et al., 2016).
Diet and Metabolic Risk
There has been extensive research conducted on the role of diet in the etiology of
metabolic risk for cardiovascular disease and T2DM (Goff et al., 2015; S. Nichols et al.,
2014; Popkin 2011; Wennberg et al., 2015). Previous investigation suggested that a diet
low in fiber from fruits, vegetables, and whole grain products and also one that is rich in
salt and energy-dense foods (mainly from saturated fat and sugar content) has a
detrimental impact on developing obesity and metabolic risks for cardiovascular disease
and T2DM (Goff et al., 2015; Wennberg et al., 2015).
Globalization and economic development have made many energy-dense food
commodities cheaper and more readily available (Hu, 2011). This adverse effect of global
trade and liberation is noticeable within the eating practice of Trinidadians and
Tobagonians. The traditional diet and food preferences transitioned over the years from
unrefined plant-based and high-fiber foods to a more Westernized diet that includes
mostly processed foods that are high in animal origin, refined fat, and sugar that cause an
alteration in body composition and metabolic disturbances (S. Nichols et al., 2014;
Popkin, 2011).
Physical Activity and Metabolic Risk
The WHO (date, as cited in Howitt et al., 2016; Xiao et al., 2016) identified
sedentary lifestyle as a significant risk factor for metabolic issues and mortality.
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Extensive literature has shown the association between sedentary behavior and an
increased risk of diabetes and cardiovascular disease (Bankoski et al., 2011; Gennuso et
al., 2015; Salonen et al., 2015). Salonen et al. (2015) assessed the intensity and volume of
physical activity (PA) concerning the MetS components and body composition among
young Finnish people. Salonen et al. suggested that more time spent inactive was
significantly related to an increased metabolic risk compared to performing moderate to
vigorous activity. PA has been found to provide meaningful health outcomes that were
associated with alteration in body composition and anthropometric measures including
WC, WHR, and BMI (Salonen et al., 2015). Huang et al. (2017) assessed categories of
PA with metabolic risk among Taiwanese workers and found a positive association
between the reduction in metabolic components such as abdominal adiposity and
improved lipid profile. Similarly, meta-analytical reviews indicated a positive association
between PA and metabolic risk in which there was a 73% chance of developing MetS
when involved in a small number of physical activities (Edwardson et al., 2012; Gennuso
et al., 2015).
Although evidence suggested that PA mitigates the problem of obesity and its
metabolic challenges (Howitt et al., 2016), physical activity is still low within the
Caribbean (Bahwah & Nunes, 2010; Howitt et al., 2016). Bahwah and Nunes (2010)
recognized that 33.4% of people living south of Trinidad did not exercise on a regular
basis. The rate of physical inactivity was comparable to the statistic provided for Jamaica
(30%). Howitt et al. (2016) reported that barriers such as hot climatic conditions, poor
physical infrastructures (lack of pavements and lighting), and social issues (security and
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safety) inhibit the promotion of physical activity within the Caribbean. Despite barriers,
promotion of physical activity and encouragement of healthy eating practices may be
beneficial as the primary and secondary prevention goals in the current study.
Problem Statement
Obesity is a global epidemic and has been documented to be a significant cause of
many chronic diseases and fatalities especially in the Americas and the Caribbean
(Ordunez et al., 2015; Pagan et al., 2017; PAHO, 2017; Traboulay & Hoyte, 2015). For
instance, the prevalence rate of obesity in T&T in 2016 was 32.2% (Central Intelligence
Agency, 2016). A recent strategic plan of the MOH (2017) also indicated that 55.7% of
people between 15 and 64 years of age were either overweight or obese. The statistics
suggested that the prevalence rate of obesity in T&T is a significant public health
concern, mainly because obesity plays a contributing role in the manifestation of
metabolic risk factors of MetS and remains an emerging health issue for many countries
(Farajian & Renti, 2008; Guan et al., 2016). In T&T, cardiovascular diseases and diabetes
are among the five leading health problems that are affecting the population (Ezenwaka
et al., 2007). T&T has a significantly higher mortality rate in diabetes and cardiovascular
than any other North American country (Chadee et al., 2013; Roopnarinesingh et al.,
2015).
Researchers have investigated obesity and metabolic risk factors for both islands
(T&T); however, previous studies such as Ezenwaka et al. (2007) and Ramsaran and
Maharaj (2017) did not solely focus on the Tobago population. Ezenwaka et al. and
Ramsaran and Maharaj included a small segment of the Tobago population in their
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investigations. However, despite this exploratory insight (Ezenwaka et al., 2007;
Ramsaran & Maharaj, 2017), there is a potential for bias and poor reliability of a study
when two unique populations such as T&T are consolidated as one society. It is
important to study each community individually. To address this limitation in the
literature, the current study was designed to investigate whether the prevalence of
metabolic risk factors correlated to abnormal obesity measures among the Tobago adult
population.
Purpose of the Study
The objectives of conducting this quantitative study were to assess whether there
was evidence of metabolic risk factors among the Tobago adult population and to
determine whether there was a correlation between elevated anthropometric
measurements and metabolic risk factors among Tobago adults ages 18 to 60 during a
workplace wellness and health-screening initiative in Tobago. I examined the correlation
between several obesity measures such as BMI, WC, and WHR with blood pressure and
fasting blood glucose readings to assess the prevalence of metabolic risk.
The dependent variables were the metabolic risk factors of high blood pressure
and high blood sugar. The independent variables were anthropometric measurements:
WC, WHR, and BMI. Correlation analysis was performed on covariates and demographic
data such as age, gender, educational background, and income bracket.
Research Questions and Hypotheses
This study was guided by four research questions and their corresponding
hypotheses:
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RQ1: What is the prevalence of previously documented metabolic risk factors
for abnormal obesity measures among a representative sample of the
Tobago adult population?
Ho1: There is no prevalence of previously documented metabolic risk factors for
abnormal obesity measures among a representative sample of the Tobago adult
population.
Ha1: There is a prevalence of previously documented metabolic risk factors for
abnormal obesity measures among a representative sample of the Tobago adult
population.
RQ2: How does the prevalence of metabolic risk factors for abnormal obesity
measures differ by gender within the Tobago adult population?
Ho2: There is no difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within the Tobago adult population.
Ha2: There is a difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within the Tobago adult population.
RQ3: What are the relationships, if any, between obesity abnormal measures and
metabolic risk factors for men and women within the ages of 18 to 60 in
Tobago?
Ho3: There is no relationship between abnormal obesity measures and metabolic
risk factors for men and women within the ages of 18 to 60 in Tobago.
Ha3: There is a relationship between abnormal obesity measures and metabolic
risk factors for men and women within the ages of 18 to 60 in Tobago.
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RQ4: Do abnormal obesity measures including body mass index, waist
circumference, and waist-to-hip ratio predict metabolic risk factors among
a representative sample of the Tobago adult population?
Ho4: Abnormal obesity measures including body mass index, waist
circumference, and waist-to-hip ratio do not predict metabolic risk factors among a
representative sample of the Tobago adult population.
Ha4: Abnormal obesity measures including body mass index, waist
circumference, and waist-to-hip ratio predict metabolic risk factors among a
representative sample of the Tobago adult population.
I used both continuous and categorical variables to examine the association
between metabolic risk factors and obesity measures (see Akoglu, 2018). Other
continuous variables included weight, height, waist, hip measurement, and demographic
information such as age and income bracket. A categorical scale was used to measure
gender, race, marital status, and education background.
Theoretical Framework
I used the SET to guide this study. SET has existed for 41 years (Cramer &
Kapusta, 2017; Ryu et al., 2017). SET is a health promotion framework that
acknowledges multiple levels of influence (Fleury & Lee, 2006). The theory was used to
evaluate behavior change at various levels (individual, interpersonal, organizational, and
community) and the cultural and biological disposition of the population (Ayala et al.,
2014; Chang et al., 2013). It is valuable to view the problem beyond the individual by
encompassing the social and environmental influences (Hill et al., 2013).
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Researchers used the SET to evaluate risk factors contributing to the increased
metabolic risk such as diabetes (Chang et al., 2013; Hill et al., 2013; Obisesan et al.,
2017; Shazhan, 2015). The etiological perspectives of metabolic risks are multifactorial.
Monteiro and Azevedo (2010) observed an interaction between genetic, metabolic, social,
and environmental factors in the development of obesity and metabolic disturbances.
Multiple influences affect behaviors, such as poor dietary habits and physical inactivity,
and are critical attributes in the manifestation of metabolic risk (Ensenyat et al., 2017).
SET was valuable in showing the full range of theoretical principles that provide an
understanding of the interrelation of obesity and metabolic risk factors (Chang et al.,
2013; Lytle, 2009; Shazhan, 2015).
Nature of the Study
A quantitative design was appropriate for the current study because of its
numerical characteristics of collected and analyzed information (see Halcomb &
Hickman, 2015). A quantitative approach allowed me to quantify the prevalence and the
relationship between the metabolic risk factors and abnormal obesity measures within the
studied population. A cross-sectional survey was appropriate to provide data to assess the
research hypotheses on the prevalence of metabolic risk factors with abnormal obesity
measures (see Setia, 2016).
Primary data were collected using a self-reported questionnaire during a
workplace health-screening initiative by a government agency. Data included information
on participants’ demographics, behavioral risk factors, obesity measures, and metabolic
risk factors. For this study, the dependent variables consisted of metabolic risk factors
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(high blood pressure and high blood sugar), while the independent variables included
abnormal obesity measures (WC, WHR, and BMI). Covariates included demographic
behavior factors such as physical activity and dietary pattern. A continuous scale was
used to measure demographic data such as age, while a categorical scale was used to
measure gender, race, marital status, and education. I expressed categorical data in
percentages that were used to express the frequency distribution of categorical variables.
A logistic regression model was used to predict the odds of developing metabolic
risk factors with obesity measures among the Tobago adult population. This model was
useful to recognize the odds ratio within prevalence studies (Petersen & Deddens, 2008).
A Pearson correlation was used to analyze the strength and the direction of the
relationship between the metabolic risk factors and abnormal obesity measures.
Definitions
Abnormal body mass index (BMI): Values of ≥ 30 kg/m² (Ramsaran & Maharaj,
2017).
Abnormal fasting blood glucose: Glucose levels greater than or equal to 100mg/dl
or 5.6mmol/l (Alberti et al., 2005; IDF, 2006; Parikh & Mohan, 2012).
Abnormal obesity measures: Anthropometric measures that include WHR values
of ≥ 0.90cm for males and ≥ 0.85cm for females, WC measurements ≥ 94cm for males
and ≥ 80cm for females, and BMI values of ≥ 30 kg/m².
Abnormal waist circumference: The values used for abnormal waist
circumference are based on the IDF recommendation cutoff values of ≥ 94cm for males
and ≥ 80cm for females (Osei-Yeboah et al., 2017).
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Abnormal waist-to-hip ratio (WHR): The values used for abnormal WHR are
based on WHO metabolic syndrome criteria. Having a WHR ≥ 0.90cm in males and ≥
0.85cm in females is a risk of MetS (P. L. Huang, 2009).
Anthropometric measurement/indices: Defined measurements used to assess and
quantify body proportions that include obesity measures such as WC, WHR, and BMI
(Bhowmik et al., 2015; Bouguerra et al., 2007; Goh et al., 2014; Olafsdottir et al., 2016;
WHO, 2000).
Body composition: The accumulation of nutrients and other substances acquired
from the environment and retained in the body. These include elements, tissues, and
organs that become building blocks that constitute mass and shape conferring to body
function (Going et al., 2014).
Body mass index (BMI): A measurement that incorporates the participant’s weight
(kg) over squared height (m²; Aynalem & Zeleke, 2018; Kyrkou et al., 2016; Nuttall,
2015; Ortega et al., 2016; Swainson et al., 2017).
Central obesity: The accumulation of fatty tissues surrounding the viscera that can
be estimated using simple measurements such as WC and WHR (Paley & Johnson,
2018).
Elevated triglyceride: A measurement equal to or greater than 150mg/dl (Alberti,
Zimmet & Shaw, 2005; IDF, 2006; Parikh & Mohan, 2012).
Hyperlipidemia: Elevated levels of lipid in the blood (L. Lee & Sanders, 2012).
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Hypertension: An elevated level of blood pressure within the range of
130/85mmHg. Hypertension is associated with diseases such as cardiovascular disease
and stroke (P. L. Huang, 2009).
Metabolic risk factors: Fasting blood glucose level ≥ 100mg/dl (Alberti et al.,
2005; IDF, 2006; Parikh & Mohan, 2012). Using the IDF and NCEP-ATP III guidelines,
a systolic blood pressure reading of ≥ 130 mmHg and a diastolic blood pressure of ≥ 85
mmHg for all participants (Assaad-Khalil et al., 2015; Ezenwaka et al., 2007; Gradidge et
al., 2016; Kaur, 2014).
Metabolic syndrome (MetS): “A cluster of metabolic risk factors including central
or visceral obesity, insulin resistance, and hypertension and lipid disorder” (Manjavong et
al., 2017, p. 55).
Obesity: An excessive accumulation of adipose tissue that measures a BMI of ≥
30 kg/m² (Ramsaran & Maharaj, 2017).
Obesity measures: Anthropometric indices that are used to assess and quantify
body proportions. For this study obesity measures included WC, WHR, and BMI
(Bhowmik et al., 2015; Bouguerra et al., 2007; Goh et al., 2014; Olafsdottir et al., 2016;
WHO, 2000).
Tobagonian: Any person who was born and lives in the island of Tobago. Tobago
is part of a twin island country of T&T located in the Caribbean (Johnson & Rodrigues,
2016).
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Waist circumference (WC): The measurement that is taken around the waistline to
identify central obesity. The IDF recommended a cutoff value for WC at 94cm for males
and 80cm for females (Osei-Yeboah et al., 2017).
Waist-to-hip- ratio (WHR): The ratio taken from dividing the measurement of the
waist (cm) by the hip (cm) measurement. According to WHO MetS criteria, having a
WHR ≥ 0.90 cm for males and ≥ 0.85cm for females is a risk of MetS (P. L. Huang,
2009).
Assumptions
The assumptions for this present study related to the type and sources of data. By
targeting 264 Tobagonians between the ages of 18 and 60 years, and participants working
within the public sector, I assumed that there would be an accurate representation of the
population. Due to the absence of reliable secondary data that included demographic,
clinical, and anthropometric data, I assumed that participants could easily self-report data
provided to them by trained health care professionals. With the use of these primary data,
the trustworthiness of the study was enhanced.
A self-reported questionnaire adapted from Behavioral Risk Factor Surveillance
Survey (BRFSS) from the Centers for Disease Control and Prevention (CDC; Garmon
Bibb et al., 2014) was used. The BRFSS required self-reporting on an individual’s
present health-related perceptions, conditions, and behaviors, as well as demographic
information (Garmon Bibb et al., 2014). I assumed that participants would answer the
questions truthfully and accurately. I reassured participants that ethical procedures would
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be followed to safeguard personal information, which included preserving confidentiality
and anonymity.
Scope and Delimitations
There are delimitations of a study according to the boundaries of the
investigation. Obesity and other metabolic risk factors remain a significant health concern
and are the leading cause of mortality in T&T (MOH, 2017). Due to the shortage in
evidence-based information regarding the issue, I investigated whether a relationship
exists between abnormal obesity measures and metabolic risk factors among Tobagonian
adults age 18 to 60 working in the public sector. Delimitations for the study included age,
ethnicity, and employment status. Participants were within the ages of 18 to 60 years,
were nationals of Tobago, and were employed in the local government. The research
population comprised a true representation of Tobagonians, which allowed for the
research findings to be generalized.
I excluded people previously diagnosed with diabetes or hypertension prior to the
health screening and individuals already taking medication for metabolic health issues.
Individuals selected for the study either had elevated levels of blood pressure ≥
130/85mmHg and fasting blood sugar levels ≥ 100mg/dl or 5.6mmol/l diagnosed during
the workplace wellness initiative. Pregnant or lactating women were excused, as were
nonnatives of Tobago.
Limitations
This study included only 270 adult Tobagonians employed within the Tobago
House of Assembly (THA). The findings cannot be generalizable to another population
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or geographic location. Another limitation was in the data collection instrument, which
was adapted from the BRFSS and contained personal information about the participants,
including present health-related perceptions, behaviors risk factors, and demographic
information (see Garmon Bibb et al., 2014; Ward et al., 2016). Given the cultural barriers
that exist in Tobago, barriers such as disease perception and acceptance, and fear of
stigmatization, participants may have withheld pertinent information (see Brathwaite &
Lemonde, 2015; Roopnarinesingh et al., 2015). Participants may not have been willing to
disclose personal information that was required to participate in the study. Shortcomings
may have existed when analyzing self-reported data of abnormal obesity measures and
metabolic risk factors and may have resulted in misclassification in identifying an
accurate prevalence rate. To mitigate this limitation, I addressed the issues of privacy,
confidentially, and informed consent. The final limitation was the cross-sectional nature
of the study. Causal inferences regarding the association between abnormal obesity
measures and metabolic risk factors could not be made because cross-sectional studies
prohibit inferences about cause-effect relationships (B. J. Lee & Kim, 2014; Setia, 2016).
Significance
The evidence showed that the prevalence of obesity and MetS is widespread
(Ramsaran & Maharaj, 2017; Villamor et al., 2017). The current study was important
because it contributed to knowledge that documents and describes the prevalence of MetS
as it relates to abnormal obesity measures in Tobago. Pinpointing the abnormal obesity
measures correlated to MetS may serve as a reference guide to clinicians when treating
the Tobagonian population.
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Understanding the extent of the problem may help public health practitioners and
policymakers to channel resources into awareness and prevention initiatives. These
initiatives may support and promote health education and promotion initiatives to curb
the emerging trend of obesity and metabolic risk factors. This research may contribute to
positive social change in the improvement of existing health standards among the target
population because MetS and obesity have been shown to have a negative impact not
only on the country’s health care expenditure but also on the life expectancy rate of the
country due to an increased risk for further health complications (see Jarolimova et al.,
2013).
Summary
In Chapter 1, I provided an introduction and background information regarding
the prevalence of metabolic risk factors and obesity measures. The emerging trend of
obesity has been recognized to be a public health concern for countries because it
negatively impacts the quality of lives and also generates economic burden to health care
expenditures and individuals’ health expenses. Obesity appears to be the driving force
behind the influx of metabolic risk factors that grossly affect a diverse spectrum of a
population and its demographics. The application of simple nonevasive obesity measures
such as BMI, WC, and WHR may easily and efficiently predict the prevalence of
metabolic risk. In Chapter 2, I provide a comprehensive overview of the literature on the
prevalence of metabolic risk factors and obesity measures.
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Chapter 2: Literature Review
The issue of obesity and MetS has become an emerging public health issue for
countries (Ordunez et al., 2015; Pagan et al., 2017; PAHO, 2017; Traboulay & Hoyte,
2015). This rising trend has resulted in investigations at local, regional, and international
levels (Farajian & Renti, 2008; Guan et al., 2016; Jarolimova et al., 2013; Ramsaran &
Maharaj, 2017; Robbins et al., 2016; Salas et al., 2017; Villamor et al., 2017; VlietOstaptchouk et al., 2014). Obesity increases an individual’s chance of developing
metabolic risk and is an important component that constitutes the MetS, leading to T2DM
and cardiovascular diseases (De Lorenzo et al., 2016; Han & Lean, 2016; Kaur, 2014;
Robbins et al., 2016). These health challenges remain the leading cause of mortality and
morbidity in T&T (Chadee et al., 2013; Ezenwaka et al., 2007; MOH, 2017; Ramsaran &
Maharaj, 2017; Roopnarinesingh et al., 2015). The increased mortality rate from these
illnesses can affect the life expectancy rate of a population (Gavurová et al, 2017; Lappa
et al., 2018). The current literature review addressed sources pertinent to the prevalence
of metabolic risk factors and obesity measures.
Literature Search Strategy
A systematic approach included several databases in health sciences and nursing
including Ovid, CINAHL, MEDLINE, and ProQuest. The research questions and other
keywords provided key terms for the search. The latter included words and phrases such
as metabolic syndrome, non-communicable disease, Type 2 diabetes, dysglycaemia,
hypercholesterolemia, hypertension, anthropometric indices, weight distribution, and
body fat. I also used Google Scholar to access information from local institutions,
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international agencies, and local health agencies in T&T. The review included evidencebased and full-text sources from within a 3- to 10-year time span that focused on the
prevalence of MetS and obesity. The structure of the review reflected relevant areas that
highlighted the existence and magnitude of metabolic risk factors as they related to the
anthropometric indices.
In this chapter, I provide a brief introduction of the issue, a description of the
literature search strategy, and an overview of obesity, obesity classification, and the
obesity measures including BMI, WC, and WHR. Additionally, the prevalence of obesity
within T&T and the regional prevalence of obesity is reviewed. Other relevant areas such
as the identification of MetS, the prevalence of MetS in T&T, and the regional prevalence
of MetS are discussed. This chapter also provides a detailed account of the theoretical
framework, the SET, which was the foundation that guided the study. This chapter
concludes with a summary of the literature review and a brief transition to Chapter 3.
Obesity
Although some cultures regard obesity as a positive sign of affluence, the
increased trend has become a public health concern for countries because it negatively
impacts health outcomes (Sohn, 2017; Verna et al., 2017). Studies affirmed obesity as a
causative factor for several health problems (Evangelista et al., 2018; Lappa et al., 2018;
Nyenhuis et al., 2018). Health agencies, researchers, and public health clinicians also
recognized obesity as a prominent and multifactorial component that generates metabolic
risk (Choi et al., 2016; Cornier et al., 2011; Egbe et al., 2014; Goh et al., 2014; Pelegrini
et al., 2014; Thomas et al., 2018). There are indications that obesity generates economic
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and social challenges for both the victims of these diseases and the country’s health care
expenditure (Cruz et al., 2014; Scholze et al., 2010; D. V. Wagner et al., 2015). The
treatment for MetS is at an economic disadvantage because it accounts for a significant
portion of the annual health care budget (Cruz et al., 2014; Scholze et al., 2010). The
expenses are categorized as direct, indirect, or intangible costs ranging from expensive
medical bills/hospitalization, loss of productivity for those within the working-class
group, and the deterioration of health during the disease progression (D. Kim et al., 2015;
Mahabaleshwarkar et al., 2016; D. V. Wagner et al., 2015).
Investigators recognized that for the past 20 years, obesity prevalence has
increased twofold within 73 countries and has caused a 70% mortality rate (Campbell,
2018). Obesity prevalence has received global recognition because it has continued to
increase among different populations according to age, gender, ethnicity, culture,
socioeconomic status, and education.
Obesity Classification
Obesity is the storage of excessive adipose tissue (Wannamethee & Atkins, 2015).
The WHO classification is frequently used to define obesity (Green et al., 2016, Wyatt,
2013). Height and weight measurements are integrated into a simple calculation to
determine the BMI (Green et al., 2016; Wyatt, 2013). The WHO referred to obesity as
having a BMI ≥ 30 kg/m2 due to overconsumption of high caloric foods or an imbalance
of energy expenditure (Nayak et al., 2016; Ramsaran & Maharaj, 2017; Tuoyire, 2018;
Wyatt, 2013). The International Obesity Task Force further extended this classification
into preobesity, Class 1 obesity, Class 2 obesity, and Class 3 obesity with a BMI of 25 to
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29.9, 30 to 34.9, 34.9 to 39.9, and 40 and above, respectively (Johnson Stoklossa et al.,
2017; Nuttall, 2015).
Obesity Measures
Investigators used body composition to assess and identify a wide range of health
issues among young and old populations (Going et al., 2014). Body composition
assessments can be implemented by using a series of laboratory measurements and field
methods (Affuso et al., 2018). The use of anthropometric indices in clinical assessments
is a reputable field method for clinicians to recognize a person’s risk of developing
metabolic issues (Cornier et al., 2011; D’Souza & Shekar, 2015). These measures are
usually cost-effective within a clinical setting and controlled by confounders such as
ethnicity and gender to determine their cutoff value or standards (Awasthi et al., 2017;
Egbe et al., 2014). Researchers examined the relationship among several measures with
the metabolic risk factors (Czernichow et al., 2011; Kassi et al., 2011; Shakiba et al.,
2017; Swainson et al., 2017).
BMI, WC, and WHR are widely used anthropometric assessments to assess
adiposity (Bhowmik et al., 2015; Bouguerra et al., 2009; Goh et al., 2014; Olafsdottir et
al., 2016; WHO, 2000). BMI measurements are the most frequently used measurements
to assess the level of obesity (Hulsegge et al., 2017; Rahmani et al., 2014), while WC and
WHR are valuable measurements to examine regional fat distribution that are linked to
other high-risk factors in the development of cardiovascular disease (Hulsegge et al.,
2017; Rahmani et al., 2014; Swainson et al., 2017).
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Body Mass Index
BMI is a simple and suitable approach to recognize the prevalence of obesity
within a population (Awasthi et al., 2017; Ortega, et al., 2016; Swainson et al., 2017).
The formula used to calculate BMI is dividing the weight in kilograms by height squared
in meters (m²) to assess obesity (Aynalem & Zeleke, 2018; Khorrami et al, 2017; Kyrkou
et al., 2016; Ortega et al., 2016; Swainson et al., 2017). The criteria for obesity are a BMI
of 30 kg/m² and above (Aynalem & Zeleke, 2018; Khorrami et al., 2017; Kyrkou et al.,
2016). Obesity has been categorized into categories of Classes 1, 2, and 3, which fall
within the range of 30 kg/m² to 35kg/m², 35kg/m² to 40kg/m², and 40kg/m² and above,
respectively (Kaplan et al., 2014).
I examined BMI to establish a relationship between the metabolic risk factors and
obesity measures. The association between BMI and several metabolic risk factors has
been well documented (Adamu et al., 2014; Chua et al., 2017; Gregory et al., 2017;
Kaplan et al., 2014; Ortega et al., 2016). Some researchers recognized a positive
relationship between BMI and metabolic risk factors, while other studies were
inconclusive (Adamu et al., 2014; Chua et al., 2017; Kaplan et al., 2014). Gregory et al.
(2017) illustrated that increasing BMI could affect the severity of coronary disease. With
an increase in BMI, the prevalence of metabolic risk factors such as hypertension,
hyperlipidaemia, and diabetes is increased significantly (Gregory et al., 2017, Kaplan et
al., 2014).
In a similar cross-sectional study, Al-Bachir and Bakir (2017) recognized BMI as
a robust predictive measure to MetS risk factors. The authors correlated blood pressure,
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fasting blood sugar, and specific lipid profile measurements with BMI among 2,064
healthy male Syrians adolescents. Al-Bachir and Bakir recognized that some clinical
measures increased significantly as the BMI increased except high-density lipoprotein
cholesterol values, which showed no effect. Similarly, Ortega et al. (2016) showed
positive correlation when examining the appropriateness of BMI as a method to predict
cardiovascular disease among a population of 60,335. Ortega et al. found a 2.7-fold
increased mortality risk for cardiovascular disease when BMI escalated.
In contrast, some studies’ findings were inconclusive. Chua et al. (2017) used
anthropometric indices to predict hypertension among 223 men and 259 women in the
Malaysian adult population. Chua et al. correlated BMI with blood pressure reading but
found BMI to be unreliable to predict hypertension. The unreliability of BMI to predict
hypertension related to the inability to distinguish between muscle mass and adipose
tissue to identify metabolic risk (Chua et al., 2017; Ortega et al., 2016).
Parks and Kim (2012) conducted a cross-sectional survey and assessed
anthropometric measures with metabolic risk factors among 2,952 Koreans age 20 to 79
with average BMI and WC. Parks and Kim observed that BMI was an unreliable measure
to predict the MetS because they could not recognize the distribution of body fat and
could not differentiate excess adipose mass from high lean muscle mass. Parks and Kim
acknowledged that the anthropometric measure WHR was a better indicator to predict
metabolic risk factors than BMI and WC. Although Battie et al. (2016) used a similar
design, this finding was not confirmed. Instead, Battie et al. found that obesity measures
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were comparable to predict hypertension and diabetes mellitus among female Filipino
Americans.
Investigators tested the relationship between variables such as age, gender, and
ethnicity with obesity measures and MetS (Kaplan et al., 2014). Kaplan et al. (2014)
looked at gender differences with BMI measures and cardiovascular risk factors among
6,547 Hispanic men and 9,797 Hispanic women. Women were more likely to become
obese and were within the obesity categories of Class 2 and 3 compared to their male
counterparts (Kaplan et al., 2014). BMI is a simple and cheap method to assess body
composition. Although previous researchers acknowledged that BMI is a common and
useful tool to recognize metabolic risk prevalence and disease progression within a wide
cross-section of a population (ages, gender, ethnicity, culture, socioeconomic
background), BMI is limited in its inability to differentiate muscle mass from body fat
(Ho-Pham et al., 2015).
Waist Circumference
Abdominal obesity is a useful measure to monitor morbidity and mortality
(Coutinho et al., 2013; Kwon et al., 2017; Oh et al., 2017; Rahman & Adjeroh, 2015).
WC was found to be the most appropriate obesity measure to determine central or
abdominal obesity (Ahmad et al., 2016). The etiology relates to the significant amount of
visceral adipose tissue that mobilizes vast amounts of metabolic activities that precipitate
metabolic risk (Elffers et al., 2017).
The application of WC has been easy and has proven to be suitable to predict and
recognize metabolic risk factors within various populations (Coutinho et al., 2013; Oh et
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al., 2017). The NCEP-ATP III and the IDF employed WC as a part of the criteria and as
a diagnostic tool to identify the MetS (Kassi et al., 2011). Both agencies recommended
different threshold values. The IDF recommended a cutoff value for WC at 94cm for
males and 80cm for females, while the NCEP-ATP III recommended criteria were >
102 cm for men and > 88 cm for women (Osei-Yeboah et al., 2017).
Shakiba et al. (2017) correlated general obesity and abdominal obesity with the
risk of developing cardiovascular disease among 12,902 participants in an
Atherosclerosis Risk in Communities study done in four U.S. states. Shakiba et al. used
body mass, WC, and WHR as part of the assessment tools. BMI was used to assess the
relationship between general obesity and cardio-metabolic risks, while WC and WHR
were used to measure abdominal obesity along with cardio-metabolic risk. Shakiba et al.
used G-estimation to analyze this relationship. The WC showed a 65% risk of developing
cardiovascular disease, while BMI and WHR were 15% and 38%, respectively. The
survival rate decreased among the participants with a higher level of abdominal obesity
regardless of WC or WHR measures (Shakiba et al., 2017).
Other researchers evaluated the relationship between WC and cardiovascular risk
factors in different cultures. Guo et al. (2016) conducted a cross-sectional study to
investigate the prevalence of MetS among 3,900 adults from Southwest China. Guo et al.
used a questionnaire, anthropometric indices, and blood test to collect data. Guo et al.
also used the IDF, the NCEP-ATP III, and the Joint Interim Statement to define MetS.
Guo et al. used the t test, chi-square test, and descriptive statistics to analyze continuous
data and categorical data, respectively. Guo et al. interpreted the odds ratio using logistic
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regression to assess the relationship between WC and metabolic risk factors. The results
showed that the odds ratio increased across gender with high cardio-metabolic risk
factors and an increased WC among participants (Guo et al., 2016). Such findings were
consistent with other studies that recognized WC as a predictor tool for cardio-metabolic
risk factors in an adult population (Lam et al., 2015; Lear et al., 2010).
Studies indicated the usefulness of WC as an obesity measure to detect metabolic
risk associated with abdominal fat (Guo et al., 2016; Lam et al., 2015; Lear et al., 2010).
Both the IDF and the NCEP-ATP sanctioned WC to be used internationally as one of the
proposed criteria to identify metabolic risks: cardiovascular disease, hyperlipidemia, and
insulin resistance (Guo et al., 2016; Kassi et al., 2011). The application of WC measures
as part of the metabolic risk algorithm in primary prevention is appropriate because the
risk generated from abnormal abdominal fat may not be detectable in some cases in
which BMI increased (Parley & Johnson, 2018). Investigators acknowledged that
measures that incorporate abdominal fat, including WC and WHR, serve as better
predictors for cardio-metabolic risk factors (Guo et al., 2016; Kassi et al., 2011; Lam et
al., 2015; Lear et al., 2010).
Waist-to-Hip Ratio
Many researchers investigated the relationship between WHR and MetS
(Czernichow et al., 2011; Dimala et al., 2018; Kassi et al., 2011; Moore et al., 2017;
Pavanello et al. 2018). Like WC, WHR was a significant indicator to determine body fat
distribution and metabolic disturbance (Kassi et al., 2011; Mousavi et al., 2015, Parley &
Johnson, 2018). The operating assumption of WHR is that an increase in visceral
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abdominal fat and decrease in glute-femoral muscle mass places a person at risk of
developing metabolic risk factors (Kassi et al., 2011; Mousavi et al., 2015). Such
assumptions may also apply even if the person is within a normal BMI category (Ahmad
et al., 2016).
The WHO endorsed WHR as one of the criteria to identify MetS (Dimala et al.,
2018; Moore et al., 2017). WHR is a reliable and straightforward measure that derives
from dividing the waist measurement by the hip measurements (Dimala et al., 2018).
Sometimes variations in research findings may occur due to different protocols used for
analysis when examining the relationship between obesity measures and metabolic risk
factors or disease outcome (WHO, 2008). Nonetheless, the recommended threshold
values for the adult population according to WHO criteria are > 0.90 for males and > 0.85
for females, but may differ according to ethnicity (Moore et al., 2017).
Authors such as Czernichow et al. (2011), Kassi et al. (2011), and Pavanello et al.
(2018) found that WHR was a superior predictor to determine mortality than WC and
BMI. Czernichow et al. (2011) used three obesity measures, WC, BMI, and WHR to
establish the strength of the relationship with metabolic risk factors among 11,140
participants within a 4.8 years’ timeframe. Multiple statistical techniques such as the Cox
proportional hazard regression model and Pearson’s chi-square test were used to examine
the hypothesis which set at a 95% confidence interval level. The result indicated that
cardiovascular outcomes were strongly related to WHR than WC and BMI (Czernichow
et al., 2011). The relative risk of developing cardiovascular diseases, coronary events and
cardiovascular death according to participants obesity measures were 1.10, 1.13, and 1.08
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for WC, respectively and 1.12, 1.17, and 1.19 for WHR respectively (Czernichow et al.,
2011). The evidence showing a relationship exists between central obesity and cardiometabolic diseases was consistent with other studies (Mousavi et al., 2015; Owolabi et
al., 2017). Using this measure had higher predictive value in detecting metabolic risk
factors in persons over 50 years (Swainton et al., 2017). Ahmad et al. (2016) found that
WHR was the better index to identify T2DM than any other measures.
The above review recognized WHR as a valuable and acceptable measure. The
WHO recommended specific cut-off values for men and women. The findings from these
reviews indicated that WHR index was a good measurement to predict metabolic risk
including T2DM. WHR being a simple obesity measure could detect central obesity and
will be a valuable asset within the metabolic risk assessment so as to reduce the
prevalence of metabolic problems that are affecting Tobago.
Prevalence of Obesity
The global epidemic of obesity was documented chronologically and
geographically (Pan American Health Organization, 2016; Singh-Ackbarali & Maharaj,
2017). The literature compared the local prevalence of obesity in T&T with regional
incidence within the rest of the Americas (Pan American Health Organization, 2016;
Singh-Ackbarali & Maharaj, 2017).
Trinidad and Tobago Prevalence of Obesity
The increased prevalence of obesity highlighted the extensiveness of metabolic
risk in T&T. Many researchers reported a significant upsurge in the incidence of obesity
among the population of Trinidad and Tobago (Batson et al., 2014; Ford & Mokdad,
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2008; Naywak et al., 2016; Ramsaran & Maharaj, 2017). Even though the emphasis of
this study was on adult obesity, it was noteworthy to highlight obesity prevalence among
children in T&T, which generated public health concern (Batson et al., 2014; Johnson &
Rodrigues, 2016). Childhood obesity can be transitioned into adulthood, with a chance of
developing one or more health problems such as cardiovascular diseases, cancer, diabetes
and stroke later in their adult lives (Gulliford et al., 2001; Johnson & Rodrigues, 2016;
Singh-Ackbarali & Maharaj, 2017). Among children, the prevalence of obesity escalated
to 400% within the past 10 years, from 2.4% to 12.5% (MOH, 2017). Statistical data
diagnosed 24% of the children within school ages of 5-24 years in T&T as preobese or
obese, with a significant proliferation amongst the 24-year-old group (Johnson &
Rodrigues, 2016; MOH, 2017).
In contrast, Singh-Ackbarali and Maharaj (2017) investigated the prevalence of
obesity amongst the adult population. There was an increase in obesity projection dated
as far back as fifty years ago for Trinidadians and Tobagonians (Singh -Ackbarali &
Maharaj, 2017). The Ministry of Health’s (2017) recent statistics revealed that 55% of the
adult population in T&T were preobese or obese. There was variation in gender
prevalence, in which men were more likely to be preobese than women, 40% and 34%
respectively, and women were more likely to be obese than men 32% and 19%
respectively (MOH, 2017).
Regional Prevalence of Obesity
In comparison to T&T, the rest of the Caribbean region and the Americas were
much affected by the obesity epidemic (Food and Agriculture Organization, 2016; WHO,
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2016). The Food and Agriculture Organization of the United Nations (FAO) reported that
approximately 360 million people within the region of Latin America and the Caribbean
were pre-obese (FAO, 2016). FAO (2016) recognized that countries such as the
Bahamas, Mexico, and Chile experienced the highest rate of 69%, 64%, and 63%
respectively. Likewise, countries such as Barbados and Antigua and Barbuda seemed to
be on par with T&T’s prevalence rate, having one of the highest statistics within the
Caribbean region, that is, 33.2% and 31% respectively (FAO, 2016; WHO, 2016).
Countries such as Guyana and Jamaica when compared to T&T had a lower obesity
prevalence rate of 21.9% and 26.8% respectively (WHO, 2016).
Researchers examined the relationship of obesity to determine if it was genderspecific. In the Caribbean, females were three times more likely to be obese than their
male counterparts (Fernandez et al 2015; Sobers-Grannum et al., 2015). Neighbouring
countries such as Barbados, Antigua, and Barbuda displayed slightly higher rates than
T&T, that is, 40.7% and 39% respectively (WHO, 2016). While countries like Guyana
and Jamaica provided a lower statistic for females, that is, 21.9% and 26.8% respectively,
than the three previously mentioned countries (WHO, 2016). Similarly, in Latin America,
Cuevas et al. (2009) observed that obesity rates were higher among women than men,
especially in countries such as Chile and Brazil.
The prevalence of obesity is a global phenomenon. From the above review, it is
obvious that the increased prevalence of obesity demands public health attention, both for
children and adults, especially since this problem could be transferred from the stages of
childhood to adulthood. Presently, T&T has one of the highest rates within the Caribbean

33
from the problem of obesity. Similarly, countries such as Antigua and Barbuda, Guyana
and Jamaica are also faced with global obesity challenges that promote metabolic
abnormalities.
Identification of the Metabolic Syndrome
The high influx of obesity has dramatically caused an upsurge in the prevalence
of MetS among many populations (Chen et al., 2017; Chopra et al., 2013; Dabou et al.,
2018; Diaz-Juarez & Suarez, 2017; Dragsbæk et al., 2016; Fergurson et al., 2010; Nolon
et al., 2017; Ranasinghe et al., 2017). MetS is often referred to as Syndrome X, insulin
resistant syndrome, and cardiometabolic syndrome (Lee & Sanders, 2012; Parikh &
Mohan, 2012; Perez et al., 2017). According to Assaad-Khalil et al. (2015), the MetS
consists of multifaceted components with interconnected physiological, biochemical,
clinical, and metabolic risk factors for T2DM and cardiovascular diseases. These
components range from abdominal obesity, insulin resistance, glucose intolerance,
dyslipidemia, high blood pressure, and increased risk of mortality (Assaad-Khalil et al.,
2015; Gradidge et al., 2016).
Various studies published definitions to guide the identification of MetS among
adults and children. For this literature review, databases such as CINAHL, Medline, Ovid
Nursing, and ProQuest Nursing and Allied Health Sources were used to ascertain various
definitions and criteria recommended by organizations. These organizations included the
International Diabetes Federation (IDF), WHO, NCEP-ATP, National Heart, Lung, and
Blood Institute (NHLBI) and the American Association of Clinical Endocrinologists
(AACE). Similarly, due to increasing prevalence in childhood obesity, MetS was found
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to be a predominant health issue among the young population (Ahrens et al., 2014;
Martino et al., 2015). One study highlighted that MetS was found among 50% of the
severely obese children (Martino et al., 2015). As a result, different criteria and
definitions from adults were developed and altered to suit young children and
adolescence due to the interferences from their physiological changes of growth and
puberty (Martino et al., 2015; Reinehr, 2016; Vanlancker et al., 2017). Ahrens et al.
(2014) recognized that definitions such as from NCEP-ATP were not appropriate for very
young children. Instead, the descriptions from the Paediatric AHA and that of Cook and
others in 2003 were the most frequently used, to classify MetS among children (Ahrens et
al., 2014; Vanlancker et al., 2017).
The MetS first surfaced by Reaven under the name Syndrome X (Lee & Sanders,
2012; Wen et al., 2015). Reaven’s definition focused on hypertension, impaired glucose
tolerance (IGT), hyperinsulinaemia, and abnormal lipid profile (Lee & Sanders, 2012).
Since then, there were various definitions developed by many international organizations
(Kwon et al., 2017; Parikh & Mohan, 2012; Wen et al., 2015). Some years later, the
WHO formulated their definition in which the main components of MetS were insulin
resistance, obesity, dyslipidemia and hypertension (Dong & Simon, 2015). The WHO
defined the MetS as having a history of diabetes mellitus with any abnormal levels of two
of the components (Dong & Simon, 2015), also included in this definition was abnormal
micro-albuminuria levels (Parikh & Mohan, 2012). The preferential criterion used by the
WHO as a parameter for obesity was either WHR or BMI (Parikh & Mohan, 2012).
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A few years later, the European Group for the Study of Insulin Resistance (EGIR)
improved the WHO definition by introducing two additional criteria selected for obesity:
hypertension and dyslipidemia. The EGIR used waist circumference as their only obesity
criterion. The National Cholesterol Education Program (NCEP) Adult Treatment Panel
III (ATP III) developed the third and most frequently used definition of the MetS, which
was later updated by the National Heart Lung and Blood Institute and the American Heart
Association. The following organization defined MetS as having three or more of the
components: hyperglycemia/insulin resistance, visceral obesity, hypertension and
atherogenic dyslipidemia (Dong & Simon, 2015).
The IDF in its definition for MetS was based on obesity rather than insulin
resistance. IDF used WC with ethnicity and gender-specific values to define central
obesity (IDF, 2006; Parikh & Mohan, 2012). With an abnormal WC ≥94 cm for men and
≥80 cm for women (Nolan et al., 2017), along with two other factors such as: raised
triglycerides ≥ 150 mg/dL (1.7 mmol/L); reduced high density lipoprotein (HDL)
cholesterol, < 40 mg/dL (1.03 mmol/L) and < 50 mg/dL (1.29 mmol/L) in male and
females respectively; raised blood pressure systolic BP ≥ 130 or diastolic BP ≥ 85 mm
Hg; and raised fasting plasma glucose (FPG) ≥ 100 mg/dL (5.6 mmol/L; Alberti et al.,
2005; IDF, 2006; Parikh & Mohan, 2012). Following this definition, IDF in a common
consensus with other organizations provided a world definition (IDF, 2006; Moore et al.,
2017; Muñoz Contreras et al., 2013). The agreement included not using central obesity as
the main component in diagnosing MetS, but instead having three or more of these five
components to identify the MetS (IDF, 2006; Moore et al., 2017; Muñoz et al., 2013).
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MetS is closely related to obesity and other metabolic disturbances. Abdominal or
central obesity forms an integral part of the MetS classification. Other parameters that
define the MetS are elevated blood pressure, abnormal lipid profiles, and diabetes-related
risk measures, with specific cut-off values. The EGIR, NCEP ATP 111, and WHO
contributed to the MetS definition. With an increased prevalence of obesity, there was a
concurrent increase in metabolic risk factors.
Trinidad and Tobago Prevalence of Metabolic Syndrome
T&T faced similarities with many developing countries with the challenges of
having large cases of metabolic disturbances (Chin et al., 2016; Ezenwaka et al., 2008;
Nichols & Crichlow, 2010; Ramdath et al., 2013). Ezenwaka et al. (2008) highlighted
that according to the IDF criteria for MetS, the problem of MetS is blatantly widespread
throughout T&T, indicating a projection in cardiovascular and diabetes disease
(Ezenwaka et al., 2008). Already, T&T is challenged with the public health battle of
having a high incidence of T2DM when compared to other countries (Ezenwaka et al.,
2013; Nayak et al., 2015; Roopnarinesingh et al., 2015). T&T ranked 10th within North
American and the Caribbean as having the highest incidence of diabetes by the IDF, and
37th in the world statistics (Nayak et al., 2015; Roopnarinesingh et al., 2015). The
incidence rate of diabetes in T&T ranged from 14 and 24 % (Ezenwaka et al., 2013).
Both diabetes and cardiovascular diseases were the most common and listed among the
five leading causes of deaths in T&T (Chadee et al., 2013; Johnson & Rodrigues, 2016).
The mortality rates from these health problems were identified to be higher in T&T than
North American countries, as reflected in the mortality rate of diabetes being ten times
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higher than those countries (Chadee et al., 2013). There was recognition that
cardiovascular diseases in T&T were at the highest peak in the Caribbean and considered
to be the leading cause of death in the country (Chadee et al., 2013; Nayak et al., 2013).
Researchers examined gender roles in the prevalence of MetS (Beigh & Jain,
2012; Lee et al., 2016). Some authors found that the risk factor which defines the MetS
differs among sexes, ages, ethnicity and geographic location (Beigh & Jain, 2012; Lee et
al., 2016). Nayak et al. (2016) used a cross-sectional research design to identify the
prevalence of three metabolic risk factors: diabetes, obesity, and dyslipidemia amongst
the population in Trinidad. Confounding factors such as geographic location in Trinidad
and ethnicity were used to compare the prevalence rate among groups (Nayak et al.,
2016). The authors in this study identified several significant findings, one being that
T2DM was more prevalent among the 40 to 60 years age group (Nayak et al., 2016).
Secondly, it was found that the prevalence of diabetes was higher among the East Indian
than the African ethnic groups (Nayak et al., 2016). Finally, based on the geographical
location in Trinidad, the findings suggested that the incidence of diabetes was higher in
the south compared to north Trinidad (Nayak et al., 2016).
Despite the limited research conducted among the population in Tobago,
Ezenwaka et al. (2007) included Tobago within their small sample when they compared
the prevalence of MetS and its parameters in T2DM patients according to the IDF MetS
definition. They found that the prevalence rate of abdominal obesity was high amongst
the Tobago population and was associated with insulin resistance regardless of gender
(Ezenwakai et al., 2007). Although the previous studies by Nayak et al. (2016) classified

38
sex and ethnicity as contributing factors of the MetS, Ezenwaka et al. (2007) recognized
that such a relationship was more evident in Trinidad than Tobago. However, distinctly
while both islands shared a potential risk in the incidence of cardiovascular disease, the
rates were higher in Tobago as compared to Trinidad (Ezenwakai et al., 2007).
Regional Prevalence of Metabolic Syndrome
The rest of the Caribbean neighbors share similar MetS characteristics to T&T, in
that there were limited evidence-based publications on the overall prevalence rates of
MetS and its components. There were few and some dated literature from countries such
as St Lucia (Cherry et al., 2014), Guadeloupe (Larifla et al., 2016), US Virgin Islands
(Tull et al., 2005), Grenada (Block et al., 2012), and Jamaica (Ferguson et al., 2010).
These countries reported an increased rate in many of the metabolic components that
govern the MetS (Sobers-Grannum et al., 2015).
Ferguson et al. (2010) implemented a cross-sectional study to assess and compare
the prevalence of the MetS amongst Jamaican adults, using the IDF and AHA/NHLBI
criteria. There was a 21% prevalence rate using the IDF criteria, and 18% when using the
American Heart Association/ the National Heart Lung and Blood Institute (AHA/NHLBI)
criteria (Ferguson et al., 2010). Ferguson et al. correlated socioeconomic factors again
using the MetS criteria from IDF. Ferguson et al. examined gender and income variances.
The prevalence of MetS was significantly higher in men of higher educational
background and income bracket than the low-income bracket, 18.8% and 4.8 %
respectively (Ferguson et al., 2010).
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Cherry et al. (2014) identified the MetS prevalence rate amongst St Lucians using
the NIH/NHLBI criteria and other modifying factors to examine the prevalence. The role
of gender was recognizable. St Lucian females were at high risk of developing MetS, as
the statistics revealed that 55% of participants had elevated cholesterol level while 56%
had abnormal waist circumference (Cherry et al., 2014). Cherry et al. aligned their
findings with other international studies which shared similarities.
Similarly, from the Grenada Strategic Plan for Health 2016-2025, the government
emphasized that cardiovascular disease, hypertension, and diabetes along with their
complications were all contributors to the leading cause of morbidity and mortality
among the older population and were regarded as public health priority areas (Ministry of
Health & Social Security [MOHSS] Government of Grenada, 2018). There was little
evidence showing the prevalence of MetS or metabolic risk factors among the Grenadian
population. A systematic review and meta-analysis by Sobers-Grannum et al. (2015)
investigated the role of gender as a social determinant of diabetes within many Caribbean
countries. The authors assessed 50 articles, seven databases, but only presented one
article by Block et al. (2012) to highlight the issue regarding Grenada prevalence
(Sobers-Grannum et al., 2015). Block et al. looked at the incidence of cardiovascular risk
factors among Grenada subgroups. The findings suggested that obesity and MetS affected
one-third of the studied participants (Block et al., 2012). Block et al. used abdominal
obesity as one of the criteria used to diagnose MetS and found a higher prevalence
amongst women than men in Grenada.
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In further studies, the researchers assessed the prevalence of MetS in Barbados.
However, due to the challenges in accessing current evidence-based literature within this
region, the study used data that was published within the last 10 years. In Barbosa et al.’s
(2011) cross-sectional study, the authors looked at the relationship between several
obesity measures with hypertension among older adults both in Barbados and Cuba.
Barbosa et al. recognized that factors such as gender, ethnicity and geographical
variances were critical contributors to the association between anthropometric indexes
and hypertension. Differences observed in the association among males and females, the
Barbadians and Cubans, and the blacks and non-blacks’ population within the two
countries (Barbosa et al., 2011). The authors correlated waist/height measurements with
gender and found that male participants had a value higher than 0.50 with a 61% risk of
developing hypertension. In comparison, there was a 76% increased risk in developing
hypertension among females whose waist circumferences were equal to 88cm or greater
(Barbosa et al., 2011). The researchers recognized that being a Cuban female and having
a BMI ≥ 28 provided a 2.8 chance of developing hypertension (Barbosa et al., 2011).
Finally, both BMI and WC exhibited a similar association for developing hypertension
amongst the male Cubans (Barbosa et al., 2011).
There was little evidence-based data found on the prevalence of MetS giving a
local and regional prospective. In this section of the review, I evaluated work done within
the last10 years. MetS affects many of the Caribbean countries, including T&T.
Cardiovascular diseases and T2DM are risk factors related to the MetS, which pose
significant health challenges in the region, and more so T&T. In T&T, these health issues
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ranked among the five leading causes of mortality, in which deaths from diabetes were 10
times higher when compared to countries in North America. In the evidence provided,
researchers concluded that confounding factors such as age, gender, ethnicity and
geographic locations were influential in the relationship and prevalence rate of MetS. I
proposed to apply the IDF and WHO definitions to conduct a comprehensive assessment
in order to identify metabolic risks, which will highlight the need for a holistic approach
in decreasing mortality and morbidity rates in T&T from such metabolic risks.
Theoretical Framework
For this study, it was prudent to recognize the basis of knowledge and its
application in the research. To identify the factors which were related to obesity and
metabolic risk factors, I employed a holistic approach to identify issues that were
interconnected. The socioecological framework guided this research.
Social-Ecological Framework
Over the years, public health researchers used the social ecological framework to
understand the interaction of the individual to the environment in conceptualizing the
high prevalence of obesity and its link to metabolic risks (Blunden et al., 2016;
Podgurski, 2016; Ryu et al., 2017). The framework is a multilayered structure and
encompasses many factors which affect behavior choices (Solomon, 2015). Its
application has gained popularity in addressing various influences of health that stemmed
from an individual, social, cultural and institutional perspective (Solomon, 2015). It
captures the physical, biological, and cultural characteristics of the individuals from an
environmental perspective.
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Researchers used the SET/framework to conceptualize multiple health-related
issues (Hill et al., 2013; Kilanowski, 2017; Ohri-Vachaspati et al., 2015; Ryu et al., 2017;
Solomon, 2015). It is widely used in various social sciences disciplines that engage in the
human development (Vélez-Agostos et al., 2017). The utilization of the socioecological
perspective to recognize factors that influence obesity can provide the significant
theoretical understanding of the increased prevalence of obesity and metabolic risk
factors (Ryu et al., 2017).
Brofenbrenner’s (1979) social-ecological framework has been in existence for the
past 41 years. Within the original model, Bronfenbrenner connected the social structure
to the individual and the environment which was responsible for one’s health outcomes
(Podgurski, 2016). Podgurski (2016) postulated that five influences belong to the
environmental system which governs human behavior: microsystem, mesosystem
exosystem, macrosystem, and chronosystem (Blunden et al. 2016; Podgurski, 2016).
Microsystem
The microsystem encompasses both the individual and interpersonal level of the
nest. It focuses on the influential role of direct relationship including the family, family
health, government, religious institution and peered influences (Blundenet al., 2016;
Holland et al., 2016; Pallan et al., 2012; Podgurski, 2016; Thomas et al., 2018). The
individual personal traits include age, gender, race, and other personal characteristics
(Holland et al., 2016; Pallan et al., 2012; Podgurski, 2016). Within the microsystem, the
family has a fundamental role in the development of lifestyle patterns and the acquisition
of knowledge and personal characteristics (lifestyle, food choices, and preferences).
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Mesosystem
The mesosystem is the interpersonal association and practices within the
microsystem (Blunden et al., 2016; Pallan et al., 2012). It connects the interplay between
the individual and several direct relationships including food production, food
availability, socioeconomic factors, employment, workplace policies, and even the role of
mass media. These influences are a significant contributor within the mesosystem with
regards to lifestyle choices and modification (Hong et al., 2016).
Exosystem
The exosystem refers to influences that highlight a broader spectrum of the
community. It provides an indirect impact that impinges on the direct relationship and
precipitates environmental barriers. These influences occur with or without the
individual’s involvement and may affect the individual indirectly such as the workplace,
neighborhood, health services, mass media, and food industry (Hong et al., 2016).
Macrosystem
The macrosystem is the blueprint of the framework that identifies the cultural,
values or social norms regarding personal choices. It is responsible for a diverse social
structure and activities that occur within the microsystem. These influences stem from
family, political, religion, social, and cultural environments, which may not ultimately
impact one’s life.
Roopnarinesingh et al. (2015) accepted the concepts of culture, the values, beliefs,
and norms in constructing barriers when treating metabolic risk factors such as diabetes
amongst the T&T culture. Cultural barriers included body size perception, disease
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perception and acceptance, fear of stigmatization, type of diet, and the use of alternative
medicine in preventing and treating metabolic risk factors (Brathwaite & Lemonde, 2015;
Roopnarinesingh et al., 2015). Most often these cultural barriers are found to be labelled
high-risk behaviors (physical activities and eating habits) and are responsible for many
adverse health outcomes (Brathwaite & Lemonde, 2015).
Chronosystem
The chronosystem is the successive stages of events that occur over a period
within the individual life processes. This construct provides historical contexts and
cultural expectations that epitomize the personal development throughout the
environmental subsystem (Killam & Degges-White, 2017; Skelton et al., 2012). These
perspectives are either normative or nonnormative transitions. The normative
development changes are culturally likely to occur such as breastfeeding practices,
involved in physical activity, food preferences, the experience of puberty, the stage of the
individual’s, education, getting married, and starting a family (Killam & Degges-White,
2017). On the other hand, nonnormative transitions within the chronological stage,
involve unexpected events such as economic constraints, stress, family, history of
metabolic risk factors, maternal weight, loss of a limb, and even death (Killam &
Degges-White, 2017).
The application of Bronfenbrenner’s (1979) social, ecological model, it provides a
theoretical understanding in the relationship between the interpersonal, intrapersonal,
organizational, societal, and public policy influences, as it relates to the increased
prevalence of the metabolic risk factors (Solomon, 2015). Focusing on the environmental
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and societal impacts are beneficial in determining individuals at risk and fostering
positive behavior changes against metabolic risk factors (Gosadi, 2016). Researchers
recognized that due to the multifactorial characteristic of the MetS, there are cooccurrences from environmental, genetic and societal influences (Gosadi, 2016; Panizzon
et al., 2015). Environmental impacts such as a shift in socioeconomic circumstances,
sedentary lifestyle, and unhealthy eating practices are causative factors for the increased
prevalence of MetS (Panizzon et al., 2015). Exhibiting transitional phenotype predisposes
an imbalance of energy, that is, where energy intake is higher than energy expenditure.
This circumstance may eventually initiate obesity and metabolic risk factors. Studies
have shown these environmental variables are significantly linked to the genetic genesis
(Clifton et al., 2017; Ventura et al., 2017).
Researchers used many approaches such as obesity map location, single genes
mutation, family segregation, and twin surveys to recognize that a positive relationship
exists between heritability genetics and body composition (Lim et al., 2012, Ventura et
al., 2017). While each influence of the social ecological framework plays a pivotal role in
metabolic risk factors assessment and reduction (Hill et al., 2013), I focused on the
individual perspective of the framework. The individual level recognized characteristics
of the individuals which includes the role of gender, socioeconomic status, education
background, and behavior risk associated with development of obesity and metabolic risk
factors.
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Summary and Transition
The prevalence of metabolic risk factors has been well established and
documented within T&T and regionally. Many researchers identified that the rising trend
of obesity has an integral role in the development of metabolic risk profiles, leading to an
increased risk of cardiometabolic issues. In the review of literature, anthropometric
indices such as WC, WHR, and BMI are simple and reliable methods used, to evaluate
the degree of obesity and to determine its predispositions to metabolic risk. International
health agencies such as IDF, NCEP-ATP111, and the Joint Interim Statement identified
evaluation of abdominal obesity as an integral component to define the MetS.
The complexities of obesity and risk factors amenable to behavior change. For
this chapter, the multifactorial nature of the SEM highlighted, conceptualized the
relationship between obesity measures and metabolic risk factors. Using such a holistic
approach afforded an understanding of the societal, environmental, and biological
circumstances in preventing and treating this issue, thus fostering positive social change.
In Chapter 3, the method to determine the prevalence of metabolic risk factors for
obesity measures amongst the Tobago adult population will be explained. The methods
will include identifying the target population, the sampling procedures and data
collection, the instrument used to collect data, and the ethical procedures relating to the
study.
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Chapter 3: Research Methodology
I addressed whether there is evidence showing metabolic risk factors among the
Tobagonian adult population and whether there is a correlation between obesity measures
and metabolic risk factors among Tobagonian adults age 18 to 60. This chapter provides
information on the research design used to carry out the study and other relevant
information such as the target population, sampling procedures, data collection
techniques, instrumentation, and ethical procedures.
Research Design and Rationale
I used an empirical research design to analyze primary data from a self-reported
survey instrument. Participants self-reported on obesity and metabolic risk factors figures
soon after receiving screening by trained nurses and registered dietitians from a local
health organization. I used a cross-sectional quantitative approach was used to carry out
this study. A cross-sectional study is a prevalence study and was appropriate to examine
the prevalence of metabolic risk factors with abnormal obesity (see Carneiro et al., 2010).
A cross-sectional study allows for the use of a survey, which was suitable to estimate the
frequency and distribution of metabolic risk with obesity measures within the studied
population (see Aslam et al., 2012). A cross-sectional design allows for information on
participants’ health status, behaviors, and metabolic risk to be collected at one point in
time, and at the same time helps generate a hypothesis (Aslam et al., 2012; Setia, 2016).
For the current study, a cross-sectional research design helped me generate a
comprehensive assay of data, which included demographics, obesity measures, and
behavioral and metabolic risk factors.
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Research Variables
The dependent variables were the metabolic risk factors of high blood pressure
and high blood sugar. A self-reported questionnaire was used during the workplace
wellness and health-screening initiative in the local government agency. The independent
variables were obesity measures: WC, WHR, and BMI. Participants self-reported on both
the obesity and metabolic risk factors after screening by trained nurses and registered
dietitians working in a local health care institution. A correlation analysis was performed
on covariates, including demographic data such as age, gender, education, and income
bracket.
Methodology
Population
The sample population was drawn from within the organizations of the local
government. Departments were included that have a workforce population greater than
100 employees. Each participant was a native Tobagonian between the ages of 18 and 60
years. The population included both men and women diagnosed with high blood pressure
and abnormal blood glucose during a workplace health-screening exercise. People who
were previously diagnosed with diabetes and hypertension before the health-screening
exercise and those taking medications for these health conditions were excluded from the
study. Pregnant and lactating mothers and nonnatives of Tobago were also excluded from
the study.
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Sampling and Sampling Procedure
According to Jones et al. (2003), having the correct sample size is critical in
answering the research questions. In prevalence studies, a small sample size influences
the null hypothesis in terms of the precision and the statistical power to acknowledge the
association of interest (Martínez-Mesa et al., 2016). Charan and Biswas (2013)
recognized that the sample size calculation is dependent on the type of study design. The
formula, n = Z² P(1-P) /d² is a simple method used to calculate sample size for crosssectional studies, where n = sample size, z = z statistics for a level of confidence (1.96), P
= expected prevalence, and d = precision of 5% (.05; Naing et al., 2006). I calculated the
expected prevalence (P) by identifying the prevalence rate found in similar studies among
the same population obtained from the literature review. A study conducted by Ezenwaka
et al. (2007) on the Tobagonian population indicated that 19.3% of Tobagonians with
non-insulin-dependent diabetes mellitus had abdominal obesity and three other risk
factors for MetS, according to the IDF criteria. The sample size formula is a normal
approximation with an additional 10% over a sample for nonresponses and missing
values (Martínez-Mesa et al., 2016; Naing et al., 2006). Using this formula, I determined
the minimum sample size for this study was 264 participants.
Convenience sampling was used to select the appropriate sample because it
provided easy and quick access to the sample population. Convenience sampling is a
nonprobability sampling technique that allows for a homogenous sample (Erikan et al.,
2016). By carrying out convenience sampling, I selected departments that had a
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workforce population greater than 100 employees. Numbers were assigned to
questionnaires instead of names to protect the privacy and anonymity of each participant.
Data Collection Strategies and Research Instrument
A self-reported questionnaire was used to obtain data. To acquire meaningful
information for the study, the questionnaire was segmented into four pertinent sections.
The significance sections included demographics, behavioral measures, obesity measures,
and metabolic risk factors (see Appendix A). This procedure allowed me to draw
inferences on hypothesis testing.
Questionnaire
The 2013 BRFSS was used to develop the instrument for the study. The BRFSS is
a cross-sectional telephone survey within the public domain (CDC, 2013). The CDC
(2013) used the BRFSS to collect prevalence data regarding risk behavior and health
status of residents age 18 years and older located in several U.S. states. Because a federal
agency developed the BFRSS and it was within the public domain, authorization was not
required from the CDC to use the instrument (see CDC, 2013).
The study questionnaire consisted of seven pages and contained 24 items divided
into four sections (see Appendix A). These four sections captured the demographic
information, obesity measures, metabolic risk factors, and behavioral risk factors data:
•

Section 1 of the questionnaire contained information on participants’
demographics. The information included participants’ gender, age, race,
marital status, education, and income bracket.
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•

Section 2 of the questionnaire contained obesity measures with four
modified items. I modified the items to allow for self-reporting on
anthropometric measures such as weight, height, waist, and hip
measurements.

•

Section 3 contained metabolic risk factors and included four items asking
participants to self-report their most recent blood sugar and blood pressure
measurements. Questions on metabolic risk factors were highlighted in
Section 3 of the questionnaire.

•

Section 4 consisted of questions about the behavioral risk factors. This
contained 10 items that captured behavioral risk factors such as tobacco
and alcohol consumption, dietary consumption pattern, and physical
activity pattern. There was a modification to dietary consumption patterns
and physical activity patterns to highlight culturally appropriate foods and
physical activity suitable for the target population.

At the end of the workplace health-screening initiative, participants self-reported
information to trained nurses and registered dietitians. I assumed that clinical procedures
followed standard protocols to ensure the reliability of the data.
Definition of Obesity Measures
Anthropometric measurements were used to identify or quantify obesity. For this
study, these measurements include WC, WHR, and BMI. According to the WHO
recommendation, having a BMI of 30 kg/m² or greater and a WHR > 0.90cm (males) and
> 0.85cm (females) indicates obesity (Alberti et al., 2005). The formula of weight in
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kilograms divided by height in centimeters squared is used to categorize BMI (S. Nichols
& Crichlow, 2010). According to IDF and NCEP-ATP III criteria, WC ≥ 94cm for males
and ≥ 80cm for females indicates central obesity (Ezenwaka et al., 2007). The values for
WHR were calculated from the formula waist measurement (cm) divided by hip
measurement (cm). BMI was categorized as the following: underweight (BMI less than
18.5kgm²), normal weight (BMI 18.5kgm² to 24.9kgm²), overweight (BMI 25kgm² to
29.9kgm²), and obese (BMI ≥ 30kgm²; see S. Nichols & Crichlow, 2010).
Definition of Metabolic Risk Factors
Participants were asked to self-report the most recent blood sugar and blood
pressure readings (questions on metabolic risk factors were highlighted in Section 3 of
the questionnaire). Metabolic risk factors were defined using the IDF and NCEP-ATP III
guidelines: a systolic blood pressure reading of ≥ 130 mm Hg and a diastolic blood
pressure of ≥ 85 mm Hg for all participants (Ezenwaka et al., 2007; Kaur, 2014).
Elevated blood pressure was defined as ≥ 130/80 mm Hg. Likewise, having a fasting
blood glucose of ≥ 100 mg/dl defined elevated blood glucose levels (see Ezenwaka et al.,
2007; Kaur, 2014). Metabolic risk factors (blood pressure range ≥ 130/85 mm Hg and
FBS ≥ 100mg/dl) were the study’s dependent variables. These were measured both as
continuous and dichotomous variables (FBS: 0 = No, 1 = Yes) or (B.P.: 0 = not selected,
1 = selected).
Reliability and Validity of Instrument
Reliability and validity are key indicators used to recognize research instruments’
strengths (Sullivan, 2011). According to Sullivan (2011), reliability is the consistency and
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the dependability of the outcomes when using an assessment instrument that provides the
same result each time used, within the same setting, and among the same population.
Validity refers to the accuracy of the measure (Heale & Twycross, 2015).
Questionnaire
The CDC (2013) developed the BFRSS as a surveillance screening tool. The
BFRSS has been used to collect data on risk factors and causes of death from chronic
disease in 50 U.S. states (CDC, 2013; Hsu et al., 2018). On an annual basis, the CDC
conducts random telephone self-reported surveys on individuals 18 years and older (Hsu
et al., 2018). The random selection allows for each person within the population to have
an equal chance to participate in the survey (Carneiro et al., 2010). The purpose of the
survey is to assess health needs and public health priorities (CDC, 2013). Due to the
BRFSS’s central role, the CDC implements continuous validation checks on its data
(Pierannunzi et al., 2013).
Pierannunzi et al. (2013) examined the trustworthiness of the BRFSS by
evaluating reports on the questionnaire’s validity and reliability in various studies.
Pierannunzi et al. used the categorical rubric to assess the quality of each study.
Pierannunzi et al. recognized that nearly all of the test/retest studies that included BRFSS
questions showed an appropriate reliability level. Pierannunzi et al. recognized that most
measures from the BRFSS were highly reliable and valid according to their evaluation of
peer-reviewed studies.

54
Self-Reporting of Obesity and Clinical Measure
The current study had a cross-sectional design in which participants were
interviewed at one point in time. I investigated 270 adult Tobagonians employed within
the government sector. No cause and effect from this study could be determined, and
findings cannot be generalized to another population or geographic location. The BRFSS
is a self-reporting instrument often used to capture prevalence data regarding risk
behavior and health status of individuals 18 years and older (CDC, 2013). Because a
federal agency developed the BFRSS and it is in the public domain, CDC authorization
was not required to use the instrument (CDC, 2013).
The current research instrument was adapted from the 2013 BRFSS to suit the
target population. Researchers used the self-reporting method to collect data on obesity
and clinical measures (Bolton-Smith et al., 2000; Heman et al., 2012; Wada et al., 2005).
Bolton-Smith et al. (2000) and Wada et al. (2005) described the self-reporting
questionnaire as a valid instrument to determine population prevalence on obesity.
Researchers questioned the validity of the data ascertained from self-reporting because
self-reporting can underestimate or overestimate (Prince et al., 2008). The threat to
validity lies in the trustworthiness of using self-reported instruments. Because
participants may not have been truthful when disclosing information, there may have
been shortcomings when analyzing the self-reported data on abnormal obesity and
metabolic risk factors. Using such data may have caused misclassification in identifying
an accurate prevalence rate.
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The accuracy of self-reporting obesity measures and metabolic risk factors may
have influenced the interpretation of the prevalence of metabolic risk with abnormal
obesity measures among the Tobagonian adult population. The issues of recall and
response bias are areas of concern for some investigators (Prince et al., 2008). Issues of
recall bias and errors were addressed in the measurement. Allowing participants to selfreport at least 1 hour after implementing a health screening conducted by qualified health
care professionals, namely nurses and dietitians, minimized poor precision in
measurements. This approach allowed participants to comfortably recall and self-report
these measures because reliability seems to be affected by time frame (Althubaiti, 2016;
Short et al., 2009). Self-reporting on data obtained from qualified medical practitioners
was assumed to be as reliable as any acquired data from other gold-standard methods,
such as medical records or physical examinations (Thawornchaisit et al., 2013).
A self-reported questionnaire was the main instrument used for the study. I asked
participants to self-report information regarding demographic information, behavioral
habits, obesity measures, and metabolic risk factors. Questions for the instrument were in
a closed format, restricting participants from providing a detailed account of the
phenomenon of interest. Some relevant information could have been excluded from the
study. This would be a threat to the internal validity of the study.
Content validity addresses the degree to which the self-reported instrument items
adequately characterize the content domain (Zamanzadeh et al., 2015). The self-reporting
instrument was adapted for the study from the 2013 BFRSS surveillance screening tool
(see CDC, 2013). The BFRSS is a self-reporting instrument often used to capture
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prevalence data regarding risk behavior and health status of individuals who are 18 years
and older (CDC, 2013). For the current study, the self-reported questionnaire consisted of
24 items divided into four sections: demographic information, obesity measures,
metabolic risk factors, and behavioral risk factors data. Including these four sections
allowed for a valid representation of the topic under investigation.
Pilot Study
As part of the instrument validation process, a pilot study was conducted to
pretest the instrument to identify any questionnaire flaws (see Hassan et al., 2006). In the
pilot study, the time frame required to complete the 24-item questionnaire was identified.
The pilot study was implemented before administering the questionnaire for the main
study. The pilot study consisted of 10 participants with similar characteristics of the main
study’s target population, selected through convenience sampling. The research
procedures followed the same format as the main study.
Data Collection Analysis Plan
SPSS Version 25 was used to analyze the research data. There were four areas
used to collect and analyze the research data: demographic information, obesity
measures, metabolic risk factors, and behavioral risk factors. Demographic data were
measured using a categorical scale; this included age, gender, race, marital status,
education background, and income bracket. Gender was categorized as a dichotomous
variable (male =1, female =0). Gender was used as a covariate to explore how the
strength and direction vary in the relationship between the metabolic risk factors and
abnormal obesity measures according to gender-specifics.
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The independent variable was obesity measures: W.C., WHR, and BMI. A
continuous scale of measurements was used for weight, height, waist, and hip
measurements. To manually calculate BMI, the formula of weight in kilograms divided
by height in centimeter squared defined BMI measurements (Nichols & Crichlow, 2010).
I categorized BMI as underweight (BMI: less than 18.5), average weight (BMI: 18.5 to
24), overweight (BMI: 25 to 29.9), and obese (BMI: ≥30).
The value for WHR was calculated from the formula: waist measurement (cm)
divided by hip measurement (cm). WHR measurements were assessed according to the
criteria of ≥ 0.90 (male) and ≥ 0.85 (female). The criteria for W.C. measurement ≥ 94cm
for males and ≥ 80cm for females. Both WC and WHR were measured on a continuous
scale. For this study, all obesity measures: BMI, WHR, and W.C., were converted to
dichotomous variables. Responses were classified as BMI ≥ 30 (0=No, 1=Yes), WHR ≥
0.90cm for male and ≥ 0.85cm for female (0=No, 1=Yes), WC: ≥ 94cm for male and ≥
80cm for females (0=No, 1=Yes).
The dependent variables were metabolic risk factors of high blood pressure
(≥130/85mmHg) and high blood sugar (≥ 100mg/dl). Notably, the dependent variables
were measured both on a continuous scale and categorical; the latter used two
measurement levels (0=No, 1=Yes).
Descriptive statistics were performed on the data collected from the sampling
population to obtain tendency and spread measures. Mean and standard Deviation was
used to provide numerical data for continuous variables, while frequencies were used to
express categorical and dichotomous variables. Cross tabulation and Pearson chi-squared
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analysis were performed on obesity measures (BMI, W.C., and WHR) and metabolic risk
factors (elevated FBS and B.P.) using categorical variables. Crosstabulation analysis was
used to assess and summarize the frequencies of the outcomes and used the Pearson chisquare test to analyze the strength and the direction of the relationship between the
metabolic risk factors and abnormal obesity measures. The strength of the relationship
was examined using Cramer’s V of association. Cramer’s V measure of association
ranges from 0 to 1, showing damaging to positive strength (Gauer et al., 2016). A
Cramer’s V value of 0.1 to 0.2 is considered a weak association, while 0.2 to 0.3 is
moderate, and a value above 0.3 is a strong relationship (Gauer et al., 2016).
A binary logistic regression analysis was conducted to examine the occurrence of
metabolic risk factors (B.P. range ≥ 130/85mm Hg and FBS ≥ 100mg/dl), as predicted by
obesity measures (WHR, W.C. and BMI ≥ 30 kg/m²). Stoltzfus (2011) found that
regression analysis helps examine a relationship between outcome variables and several
independent variables. One of this test’s assumptions is that independent variables are
usually measured using nominal, ordinal, interval/ ratio. Petersen and Deddens (2008)
found that the logistic regression model is suitable to identify the ratio of odds within
prevalence studies. The assumption of using the binary logistic regression method was
not violated by having a definite outcome. To implement binary logistic regression
analysis, the dependent variable, metabolic risk factors: B.P. range ≥ 130/85 mm Hg and
FBS ≥ 100mg/dl have two values (FBS: 0=No, 1=Yes) or (B.P.: 0=not selected,
1=selected). Obesity measures, W.C. and WHR, used scale measurements, while BMI
was the categorical scale of measurement. Using binary logistic regression, a model was
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created that best fit the data and differentiated the occurrences of metabolic risk factors
among the sampling population. Finally, a significance value of 0.05 was used for each
statistical test.
Research Questions and Hypotheses
RQ1: What is the prevalence of previously documented metabolic risk factors
for abnormal obesity measures amongst a representative sample of the
Tobago adult population?
Ho1: There is no prevalence of previously documented metabolic risk factors for
abnormal obesity measures amongst Tobago adult population.
Ha1: There is a prevalence of previously documented metabolic risk factors for
abnormal obesity measures amongst Tobago adult population.
RQ2: How does the prevalence of metabolic risk factors for abnormal obesity
measures differ, by gender within Tobago adult population?
Ho2: There is no difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within Tobago adult population.
Ha2: There is a difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within Tobago adult population.
RQ3: What are the relationships, if any, in obesity abnormal measures and
metabolic risk factors for the males and females within the ages of 18 to
60 years in Tobago?
Ho3: There is no relationship between abnormal obesity measures and metabolic
risk factors for males and females within the ages of 18 to 60 years in Tobago.
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Ha3: There is a relationship between abnormal obesity measures and metabolic
risk factors for males and females within the ages of 18 to 60 years.
RQ4: In what way do abnormal obesity measures including body mass index,
waist circumference, and waist- to- hip ratio predict metabolic risk factors
among a representative sample of the Tobago adult population?
Ho4: Abnormal obesity measures including body mass index, waist
circumference, and waist- to- hip ratio do not predict metabolic risk factors among a
representative sample of the Tobago adult population.
Ha4: Abnormal obesity measures including body mass index, waist
circumference, and waist- to- hip ratio do predict metabolic risk factors among a
representative sample of the Tobago adult population.
Ethical Consideration and Negotiation Access
Before data collection, I adhered to the governance outlined by the local
government agencies (Appendices C, D, & E), the Walden University School of Health
Sciences, and also the Institutional Review Board of Walden University (Approval
Number12-16-19-0628453). Given sensitive and personal information about human
participants examined in the study, ethical consideration is essential to protect
participants and the researcher (Broom, 2006; Yip et al., 2016). Ethical issues will
improve the quality of the data retrieved (Broom, 2006). For the current study, the issues
of privacy, confidentiality, and informed consent were addressed. The participants were
provided with a synopsis of the study before the data collection procedure, which allowed
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them to decide whether to contribute to the study. Each volunteer was given the study’s
consent form before participating in the survey.
Personal and sensitive data was also captured. Confidentiality and anonymity
were critical elements throughout the study (Creswell, 2007). To adhere to ethical
guidelines, numbers were assigned to the questionnaires instead of names to protect each
participant’s privacy and anonymity and did not disclose the name of the institution
where the study took place. Finally, the questionnaires were stored in a locked file for a
period of 5-years.
Summary and Transition
Chapter 3 was an explanation of the plan of a quantitative cross-sectional research
design and methodology. It included an overview of the target population, the sample,
and the procedures intended to study a success that included ethical issues, data collection
instruments, and the method to analyze data. Chapter 4 consists of a detailed account of
the study data collection procedure, including the final timeframe for data collection that
was implemented, demographic information of the representative sample, whether any
barriers to the proposed data collection plan existed, and the statistical findings for results
of the data collection supported by visual statistics.
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Chapter 4: Results
A cross-sectional and quantitative investigation was carried out to assess evidence
of metabolic risk factors and determine whether there is a correlation between abnormal
obesity measures and metabolic risk factors among Tobagonian adults age 18 to 60. This
chapter focuses on the results guided by four research questions and associated
hypotheses:
RQ1: What is the prevalence of previously documented metabolic risk factors
for abnormal obesity measures among a representative sample of the
Tobagonian adult population?
Ho1: There is no prevalence of previously documented metabolic risk factors for
abnormal obesity measures among the Tobagonian adult population.
Ha1: There is a prevalence of previously documented metabolic risk factors for
abnormal obesity measures among the Tobagonian adult population.
RQ2: How does the prevalence of metabolic risk factors for abnormal obesity
measures differ by gender within the Tobagonian adult population?
Ho2: There is no difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within the Tobagonian adult population.
Ha2: There is a difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within the Tobagonian adult population.
RQ3: What are the relationships, if any, in obesity abnormal measures and
metabolic risk factors for men and women within the ages of 18 to 60 in
Tobago?
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Ho3: There is no relationship between abnormal obesity measures and metabolic
risk factors for men and women within the ages of 18 to 60 in Tobago.
Ha3: There is a relationship between abnormal obesity measures and metabolic
risk factors for men and women within the ages of 18 to 60 years in Tobago.
RQ4: In what way do abnormal obesity measures including body mass index,
waist circumference, and waist-to-hip ratio predict metabolic risk factors
among a representative sample of the Tobagonian adult population?
Ho4: Abnormal obesity measures including body mass index, waist
circumference, and waist-to-hip ratio do not predict metabolic risk factors among a
representative sample of the Tobagonian adult population.
Ha4: Abnormal obesity measures including body mass index, waist
circumference, and waist-to-hip ratio predict metabolic risk factors among a
representative sample of the Tobagonian adult population.
Pilot Study
A pilot study was conducted soon after gaining ethical committee approval from
Walden Institutional Review Board (Approval Number 12-16-19-0628453) and the
various government organizations (see Appendices C, D, and E) responsible for the
collection sites. The research protocol outlined for the main study was followed, in which
participants were recruited during the workplace wellness program carried out by health
professionals. A pilot study was used as a validation process to detect any flaws in the
24-item questionnaire (see Appendix A) to assess recruitment strategies, including the
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timeline required to complete the survey. Pilot studies are helpful to assess the strength of
critical variables’ relationships (Cope, 2015).
For the pilot study, I recruited the first 10 participants who suited the main study
criteria, including six women and four men. The research instrument was a self-reported
questionnaire adapted from the 2013 BRFSS (CDC, 2013). The BRFSS questionnaires
are often used to capture self-reporting data regarding risk behavior and the health status
of individuals 18 years and over (CDC, 2013). To establish the instrument’s face validity,
I administered the self-reported questionnaire to participants within the pilot study to
determine whether the questions were clear to them. The questionnaire did not require
any significant modification except to correct minor typos. The questionnaire took an
average of 8 minutes to complete. Data obtained from the pilot study were not subjected
to further statistical analysis.
Data Collection
The data collection process as described in Chapter 3 was delayed due to the
outbreak of the COVID-19 pandemic. The data collection took place within 3 months,
from March to June 2020. To conduct the study, I gained approval from the IRB at
Walden University and from the ethics committee responsible for the data collection sites
(see Appendices C, D, and E). The study was advertised by distributing flyers (see
Appendix B) to 26 government worksites within 1 to 2 weeks before the health-screening
initiative. The inclusion criteria were followed for the selected sites with a workforce
population greater than 100 employees.
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Within the first 3 weeks of March 2020, trained nurses and registered dietitians
conducted screening at nine workplaces according to the government divisions’ planned
schedule. During the screening exercise, I informed potential participants who expressed
a desire to participate in the study of the requirements and procedures required to
complete the survey. Participants were informed of the inclusion and exclusion criteria
for the study.
The inclusion criteria were native Tobagonians between the ages of 18 to 60
years. All participants were employed within the government divisions at the time of
recruitment and data collection. Included were both male and female participants
diagnosed with high blood pressure and abnormal blood glucose during this workplace
health-screening exercise. People previously diagnosed with diabetes and hypertension
before the health-screening exercise and those taking medications for these health
conditions were excluded. Pregnant and lactating mothers and nonnatives of Tobago were
excluded from the study.
During the initial recruitment phase, the data collection process was
straightforward, as outlined in Chapter 3. The potential participants who expressed an
interest in participating in the study were given the consent form, followed by the selfreported questionnaire soon after the health-screening exercise. Participants needed to
complete the self-reported questionnaire soon after implementing the health-screening
exercise conducted by health care professionals because it provided a short time frame to
answer the questions, which reduced the recall bias (see Althubaiti, 2016). Trained and
qualified health professionals recorded health data and gave each participant a health
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report card at the end of the screening, allowing participants to easily self-report
information about their metabolic risk factors and obesity measures. This procedure
helped to reduce the recall bias when using a self-reporting instrument (see Althubaiti,
2016).
After several weeks of screening, most workplaces applied protocols to reduce the
risk and transmission of COVID-19. Also, the health institution halted its workplace
wellness programs for 2020. Initially, social distancing practices within the workplaces
restricted social gatherings to a minimum of five people. Contact information was
collected for the potential participants who were unable to congregate after screening to
adhere to the protocols. The potential participants who expressed an interest in
participating in the study were contacted by telephone soon after their screening and
informed of the study’s details. The participants were allowed to ask questions about the
study. Participants were told to place the completed questionnaires in the drop box
assigned for this purpose in a secured area of the workplace.
I placed the research flyer (Appendix B), study questionnaires, consent forms, and
pencils near the secured research drop box at the different sites. The secure areas were
provided and controlled by the management of each institution. Each workplace was
given adequate research resources according to the number of people who indicated an
interest in contributing to the study. Due to strict social gathering rules in the workplace,
the recruitment procedure took a more extended period because participants worked on a
rotation schedule. The drop boxes were collected within 1 to 5 days after the screening
exercise. The management of these government agencies arranged the date and time for
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collection. The entire data collection process took 3 months to complete and included 270
participants who satisfied the selection criteria.
Statistical Analysis
After raw data were obtained, they were cleaned and analyzed. SPSS Version 25
software was used to conduct descriptive and inferential statistics. Descriptive statistics
were used to describe, summarize, and present data in a meaningful way.
Demographic data was measured using a categorical scale; demographic variables
included age, gender, race, marital status, education, and income bracket. Gender was
categorized as a dichotomous variable (male = 1, female = 0). Gender was used as a
covariate variable to explore the strength and direction of the relationship between
metabolic risk factors and abnormal obesity according to gender specifics.
The independent variables were elevated anthropometric measures, referred to as
obesity measures: WC, WHR, and BMI. A continuous scale was used consisting of
weight, height, waist, and hip measurements using metric values. BMI was manually
calculated using the formula of weight in kilograms divided by height in centimeters
squared (see S. Nichols & Crichlow, 2010). BMI was categorized into four categories:
underweight (BMI of less than 18.5 kg/m²), normal weight (BMI of 18.5 to 24.9 kg/m²),
overweight (BMI of 25 to 29.9 kg/m²), and obese (BMI ≥ 30 kg/m²; see S. Nichols &
Crichlow, 2010). WHR was calculated using the waist measurement formula in
centimeters divided by hip measurement in centimeters. The WHR values were assessed
according to the criteria of ≥ 0.90cm (male) and ≥ 0.85cm (female; see Alberti et al.,
2005). I used IDF and NCEP-ATP III criteria for WC, which defined central obesity as ≥
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94cm for males and ≥ 80cm for females (see Ezenwaka et al., 2007). Both WC and WHR
were measured using a continuous scale. However, for this study, all
obesity/anthropometric BMI measures were converted to dichotomous variables.
Responses were classified as BMI ≥ 30mg/ m² (0 = No, 1 = Yes), WHR of ≥ 0.90cm
(male) and ≥ 0.85cm (female; 0 = No, 1 = Yes), and WC of ≥ 94cm for male and ≥ 80cm
for females (0 = No, 1 = Yes). The dependent variables of metabolic risk factors were
converted to dichotomous variables: blood pressure range ≥ 130/85mm Hg (0 = not
selected, 1 = selected) and FBS levels ≥ 100mg/dl (0 = No, 1 = Yes).
Demographic Characteristics of Sample
For the study, a total of 270 participants met the inclusion criteria. The sampling
population’s demographic characteristics are displayed in Table 1, including gender, age
categories, race, marital status, highest level of school completed, and income from all
sources. The sample included both men and women, 27.0% (73) and 73.0% (197),
respectively. The participants’ age ranged from 18 to 60 years and had a mean age of
39.91 with a standard deviation of 10.100 years. Many participants were within the age
group of 35 to 44 years. The smallest category of participants (5.6%) were within 18 to
24 years.
Regarding race, participants identified as being Black, mixed-race, Indian, and
White. However, most participants identified as Black (87.4%). All participants provided
information on their marital status. Many participants (47%) never got married. A total
of 57.5% of men never got married in comparison to 43.1% of women. However, more
women (49.2%) than men (37%) self-reported as being married.
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Table 1 also includes statistics regarding the highest level of school completed by
268 respondents. One third of participants (33%) obtained a postgraduate degree
education, while a small fraction of (6.7%) completed only elementary/primary school
as the highest level of education. More women (41.5%) than men (11%) obtained the
highest level of education. The relationship between gender and the highest education
level was statistically significant, χ2 =50.17, p value = 0.00. The strength of the
relationship was moderate, Cramer’s V value = 0.43.
A large portion of the sample population (38.1%) self-reported as having a
monthly income greater than 10,000.00TT dollars while a small portion (3.3%) earned
between 1000.00 and 2,999.00TT dollars. There were 50% of women in the highest
income category compared to 20% of men. The relationship between highest income
from all sources was statistically significant, χ2 = 31.06, p value = 0.00. The
relationship’s strength was moderate, Cramer’s V value = 0.36 (Table 1).
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Table 1
Samples Demographic Characteristics
Baseline characteristics

Male samples
%(N)

Female samples
%(N)

Total sample
% (N)

Gender

27% (n=73)

73% (n-197)

100% (n=270)

4.1% (n=3)
28.8% (n=21)
37.0% (n=27)
19.2% (n= 14)
11.0% (n =8)

6.2% (n =12)
26.2% (n =51)
33.8% (n =66)
22.1% (n = 43)
11.8% (n =23)

0% (n =0)
93.2% (n =68)
1.4% (n =1)
5.5% (n =4)

0.5% (n =1)
85.3% ( n =168)
1.5% (n =3)
12.7% (n =25)

Ages:
18 to 24 years
25 to 34 years
35 to 44 years
45 to 54 years
> 55years
Race:
White
Black
Indian
Mixed-race
Marital Status
Never Married
Married
Divorced
Widowed
Separated

57.5%, (n=42)
37.0%, (n=27)
2.7%, (n =2)
1.4%, (n =1)
1.4%, (n =1)

Highest Level of
School Completed:
Elementary/Primary
Secondary
Technical Vocational
College /University
Post Grad. Degree

Income
from
sources:
< $1000
$1000 to $2999
$3000 to $4999
$5000 to $6999
$7000 to $9999
> $10,000

43.1%, (n =85)
49.2%, (n =97)
3.6%, (n =7)
2.0%, (n -4)
2.0%, (n =4)

Note. p value ≤ 0.05*

N = 268
5.6% (n=15
26.9% (n=72)
34.7% (n =93)
21.3% (n = 57)
11.6% (n=31)
N=270
0.4% (n =1)
87.4% (n =236)
1.5% (n =4)
10.7% (n =29)

0.921, 0.922

N = 270

4.44, 0.35

15.1% (n =11)
49.3% (n =36)
17.8% (n =13)
6.8% (n =5)

3.6% (n =7)
21.5% (n =42)
9.7% (n =19)
23.6% (n =46)

6.7% (n =18)
29.1% (n =78)
11.9% (n =32)
19.0% (n =51)

11.0% (n =8)

41.5% (n =81)

33.2% (n =89)
N = 246

1.5% (n =1)
8.8% (n =6)
23.5% (n =16)
35.3% (n =24)
10.3% (n =7)
20.6% (n =14)

1.7% (n =3)
1.7% (n =3)
10.7% (n =19)
18.0% (n =32)
18.0% (n =32)
50.0% (n = 89)

3.34, 0.343

47.0%, (n =127)
45.9%, (n =124)
3.3%, (n =9)
1.9%, (n -5)
1.9%, n =5)
N = 268

All

χ2, p value

1.6% (n =4)
3.7% (n =9)
14.2% (n =35)
22.8% (n =56)
15.9% (n =39)
41.9% (n = 103)

50.17, 0.00*

31.06, 0.00*
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Obesity Measures of Sample
Obesity measures refer to three anthropometric measurements that are used to
quantify or identify obesity. The measures included WHR, WC, and BMI. Table 2
presents descriptive statistics of self-reported obesity measures for the total sample. Data
showing participants weight without shoes measured in kilograms (M = 87.08, SD =
18.29), height without shoes measured in meters (M = 1.69, SD = .095), waist
measurement in centimeters (M = 94.35, SD = 12.93), hip measurements in centimeters
(M = 111.65, SD = 12.58), WHR (M = .844, SD = .069), and BMI (M = 30.69, SD =
6.56).
Table 2 displays the descriptive statistics of self-reported obesity measures for the
entire sample population and confounding for gender. These statistics included the weight
without shoes measured in kilograms, men (M = 90.60, SD = 20.41), women (M = 85.78,
SD = 17.31); BMI men (M = 28.51, SD = 5.70), women (M = 31.50, SD = 6.68). The
cutoff points used for WC values were 94 cm and 80 cm, and WHR values of 0.90 and
0.85 for men and women, respectively (see Alberti et al., 2006). The WC values were
measured in centimeters, men (M = 93.38, SD = 14.49) and women (M = 94.79, SD =
12.36), while WHR in centimeters for men was (M = .87, SD = .058) and women (M =
.836, SD = .071).
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Table 2
Descriptive Statistic for the Average Obesity Measures and Metabolic Risk Factors
(Mean ±SD)
Variables
Weight without shoes (kg) for
the total participants
Male
Female
Height without shoes(m) for
the total participants
Male
Female
Waist Measurements (cm) for
the total participants
Male
Female
Hip measurements (cm) for the
total participants
Male
Female
Waist/Hip Ratio for the total
participants
Male
Female
Body Mass Index kg/m² for the
total participants
Male
Female

Means (M)

Standard deviation (±SD)

87.08

18.29

90.60
85.75
1.69

20.41
17.31
0.10

1.78
1.65
94.35

0.08
0.75
12.93

93.38
94.79
111.65

14.49
12.36
12.58

106.8
113.44
0.844

12.05
12.32
0.07

0.87
0.836
30.69

0.58
0.07
6.56

28.51
31.50

5.70
6.60
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Table 3 displays the statistics of the frequency for participants’ obesity measures.
In this present study, abnormal obesity measures (AOM) were referred to as elevate
anthropometric measures: WHR, W.C., and BMI values. Abnormal waist circumference
was used to define elevated waist circumference values according to the IDF
recommendation cut-off values, 94cm for males and 80cm for females (Osei-Yeboah et
al., 2017). Abnormal WHR were elevated WHR based on WHO MetS criteria: WHR
>0.90cm in male and > 0.85cm in the female (Huang, 2009). This study’s abnormal BMI
refers to BMI values of ≥ 30 kg/m² (Ramsaran & Maharaj, 2017).
A large proportion of the sampling population (82.2%, n=222) had abnormal WC,
while 52.6% (n=142), BMI was greater than 30kg/m² and 38.2% (n=104) had abnormal
WHR. When comparing the frequency distribution of obesity measures according to
gender, it was obvious that females were more likely to have abnormal obesity measures
of WHR, W.C., and BMI ≥ 30kg/m² than the male participants. The frequency
distributions of abnormal obesity measures for the male samples were BMI: 38.4%
(n=28), WC: 57.5% (n=42), and WHR: 31.5% (n=23). However, the frequency
distribution for abnormal obesity measurements for the female samples was BMI: 57.9%
(n=114), WC: 91.4% (n=180), and WHR: 41.1% (n=81). A large proportion of the
sampling population (82.2%) had abnormal W.C., while 52.6% BMI was greater than
30kg/m² and 38.2% had abnormal WHR. Pearson chi-square found a positive relationship
for BMI >30kg/m² and gender and W.C. and gender. However, although the relationship
between variables was positive, the relationship between BMI >30kg/m² and gender was
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weak (Cramer’s V =0.00). On the other hand, there was a strong relationship between
W.C. and gender (Cramer’s V =0.40, Table 3).
Table 3
Prevalence of Abnormal Obesity Measures (AOM) in Relation to Gender
Variables

Male
participants

Female
participants

Total
population

χ2, p value

Body Mass Index
≥30kg/m² (Yes)

28 (38.4%)

114 (57.9%)

142 (52.6%)

8.13, 0.0*

Abnormal WC (cm)
Male ≥ 94cm and
Female ≥ 80cm

42 (57.5%)

180 (91.4%)

222 (82.2%)

41.72, 0.00*

Abnormal WHR (cm)
Male ≥ 90cm and
Female ≥ 85cm
Note. p-value ≤ 0.05*

23 (31.5%)

81 (41.1%)

104 (38.5%)

2.08, 0.15

Metabolic Risk Factors of Sample
Table 4 presents the frequency distribution of metabolic risk factors of systolic
blood pressure ≥ 135mm Hg, diastolic blood pressure ≥ 85mm Hg, and fasting blood
sugar level ≥ 100mg/dl. The cut-off points were based on the IDF. From the sampling
population, 63.3% (n=170) had their systolic B.P. values ≥ 135mm Hg, while 59.6%
(n=161) diastolic were ≥ 85mm Hg. Also, 47.9% (n=161) of the total sampling
population self-reported having both elevated systolic and diastolic, according to the cutoff point set by the International Diabetes Federation definition for MetS. The prevalence
of elevated B.P. was higher among males (64.4%) than females (41.6%).
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For this study, 61.9% of the population self-reported having FBS level ≥ 100
mg/dl. A large proportion of female participants than male participants have FBS level ≥
100mg/dl, 65% versus 53.4% respectively (Table 4).
Table 5 displays the descriptive statistics for metabolic risk factors. These
statistics included the fasting blood sugar for the total sampling population (M=13.37,
SD=45.56), for male samples (M=114.05, SD=48.75) and for female samples (M=111.55,
SD =35.82). Table 5 includes descriptive statistics of systolic blood pressure for the total
sampling population (M = 135.10, SD = 18.85), for male samples (M=142.89, SD =
19.80) and for female samples (M=132.22, SD = 17.68). Similarly, Table 5 contains the
descriptive statistics of diastolic blood pressure for the total sampling population (M =
83.63, SD = 12.67), for male samples (M=81.43, SD = 11.97) and for female samples
(89.55, SD = 12.67).
Table 4
Prevalence of Elevated Metabolic Risk Factors in Relation to Gender
Male
participants

Female
participants

Total
population

χ2, p value

Elevated Systolic BP

55 (75.3%)

116 (58.9%)

171 (63.3%)

6.21, 0.01*²

Elevated Diastolic BP

57 (78.1%)

104 (52.8%)

161 (59.6%)

14.15, 0.00*¹

Blood Pressure (BP)
≥130/80mm Hg

47 (64.4%)

82 (41.6%)

129 (47.8%)

11.06, 0.00*³

Fasting Blood Sugar
≥100mg/dl

39 (53.4%)

128 (65%)

167 (61.9%)

3.01, 0.08

Variables

Note. p-value ≤ 0.05*
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Table 5
Average Metabolic Risk Factors (Mean ±SD)
Variables
Fasting Blood Sugar
≥100mg/dl
Total Population
Male
Female
Systolic Blood Pressure ≥
130 mm Hg
Total Population
Male
Female
Diastolic Blood Pressure ≥
85mm Hg
Total Population
Male
Female

Means (M)

Standard deviation (±SD)

113.37
114.05
111.55

45.56
48.75
35.82

135.10
142.89
132.22

18.85
19.80
17.68

83.63
81.43
89.55

12.67
11.97
12.67

Behavior Risk Factors of Sample
Table 6 displays a summary of self-reported behavior risk factors for the sampling
population, including salt intake, cigarette use, and physical activity levels. Other
behavior risk factors were alcohol intake, fruit and vegetable intake, sugar-sweetened
juice consumption, and the consumption of 100% fruits juice, were all measured using a
5-point Likert scale (never, 1-7 days, 8 to 14 days, 15 to 21 days and greater than 21
days).
The frequency statistics showed that most participants (n=160, 59.3%) were
watching their salt intake compared with those who were not watching their salt intake
(n= 106, 39.8%). A greater proportion of participants consumed fruits and vegetables
more than 21 days in the month, 32.2% (n=87) and 27% (n=73). Likewise, more
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participants (27%, n=73) consumed sugar-sweetened drinks such as sports and energy
drinks more than 21 days in the month. Eighty-two participants (30.4%) never consumed
100% fruit juices in the past month, and only 11. 9% (n=32) consumed 100% fruit juice
more than 21 days (see Table 6).
The frequency statistics showed that 48.9% (n=132) of participants never
consumed alcohol within the past month. In comparison, 33% (n=89) consumed alcohol
at least 1 to 7 days within the month, 8.1% (n=22) consume alcohol more than 21 days in
the month, and 1.1% (n=3) and 3% (n= 8) consumed alcohol at least a total of 15 to 21
days and 8 to 14 days respectively. The majority (90.7%, n=245) of participants did not
smoke at all, 4.4% (n=12) smoked cigarettes some days, while a small proportion of 3%
(n=8) smoked cigarettes every day.
Regarding physical activity (P.A.), only 99.3% (n=268) of the sampling
population self-reported their physical activity habits. 69.6% (n=188) were involved in
physical activity, while 29.6% (n=80) did not participate in physical activity.
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Table 6
Frequency Table of Behavioral Risk Factors
Variables
How many times do you
consume fruits within the
month?

How often do you drink sugarsweetened drinks in 30 days?

How often do you drink 100%
fruit juices within the month?

How often do you consume
vegetables within the month?

Are you watching your salt
intake?

Drink alcoholic beverages
within 30 days?

Do you smoke cigarettes every
day?

Did you participate in any
physical activities?

Categories
Never
1 to 7 days
8 to 14 days
15 to 21 days
Greater than 21 days
Refused/Don’t know/ Not sure
Never
1 to 7 days
8 to 14 days
15 to 21 days
Greater than 21 days
Refused/Don’t know/ Not sure
Never
1 to 7 days
8 to 14 days
15 to 21 days
Greater than 21 days
Refused/Don’t know/ Not sure
Never
1 to 7 days
8 to 14 days
15 to 21 days
Greater than 21 days
Refused/Don’t know/ Not sure
Yes
No
Refused/don’t know/not sure

Never
1 to 7 days
8 to 14 days
15 to 21 days
Greater than 21 days
Refused/Don’t know/ Not sure
Every day
Some days
Not at all
Refused/Don’t know/ Not sure
Yes
No
Refused/Don’t know/Not sure

Frequency of sample
270 Respondents
11
36
46
63
87
27
270 Respondents
69
66
29
14
73
19
270 Respondents
82
73
31
14
32
38
270 Respondents
6
59
61
52
73
19
270 respondents
160
106
4
270 Respondents
132
89
8
3
22
16
270 Respondents
8
12
245
5
270 Respondents
181
89
0

Percentages %
4.1%
13.3%
17.0%
23.3%
32.2%
10.0%
25.6%
24.4%
10.7%
5.2%
27.0%
7.2%
30.4%
27.4%
11.5%
5.2%
11.9%
14.1%
2.2%
21.9%
22.6%
19.3%
27.0%
7.0%

59.3%
39.3%
1.5%
48.9%
33%
3.0%
1.1%
8.1%
5.9%
3.0%
4.4%
90.7%
1.9%
67.0%
33.0%
0%
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Research Questions and Hypotheses
Inferential statistics were used to present results for the research questions. There
were three inferential statistics used within the study crosstabulation, chi-squared, and
binary logistic regression. Four research questions and their associated hypotheses were
developed to acquire data examining the prevalence of metabolic risk factors with
abnormal obesity measures among Tobagonians, ages 18 to 60. They are as follows:
RQ1: What is the prevalence of previously documented metabolic risk factors
for abnormal obesity measures amongst a representative sample of the
Tobago adult population?
Ho1: There is no prevalence of previously documented metabolic risk factors for
abnormal obesity measures amongst Tobago adult population.
Ha1: There is a prevalence of previously documented metabolic risk factors for
abnormal obesity measures amongst Tobago adult population.
RQ2: How does the prevalence of metabolic risk factors for abnormal obesity
measures differ, by gender within Tobago adult population?
Ho2: There is no difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within Tobago adult population.
Ha2: There is a difference with the prevalence of metabolic risk factors for
abnormal obesity measures by gender within Tobago adult population.
RQ3: What are the relationships, if any, in obesity abnormal measures and
metabolic risk factors for the males and females within the ages of 18 to
60 years in Tobago?
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Ho3: There is no relationship between abnormal obesity measures and metabolic
risk factors for males and females within the ages of 18 to 60 years in Tobago.
Ha3: There is a relationship between abnormal obesity measures and metabolic
risk factors for males and females within the ages of 18 to 60 years.
RQ4: In what way do abnormal obesity measures including body mass index,
waist circumference, and waist- to- hip ratio predict metabolic risk factors
among a representative sample of the Tobago adult population?
Ho4: Abnormal obesity measures including body mass index, waist
circumference, and waist- to- hip ratio do not predict metabolic risk factors among a
representative sample of the Tobago adult population.
Ha4: Abnormal obesity measures including body mass index, waist
circumference, and waist- to- hip ratio do predict metabolic risk factors among a
representative sample of the Tobago adult population.
To answer Questions 1, 2, and 3, categorical variables were used to carry out
cross-tabulation and Pearson chi-square test (χ2). Variables were measured using
dichotomous scale. Participants’ responses were classified as gender (female = 0, male
=1), BMI ≥30mg/ m² (0 = No, 1 = Yes), WHR of ≥ 0.90cm (male) and ≥ 0.85cm (female
(0 = No, 1 = Yes) and WC of ≥ 94cm for male and ≥ 80cm for females (0 = No, 1 = Yes).
The dependent variables, metabolic risk factors were measured using dichotomous scale,
(blood pressure range ≥ 130/85mm Hg (0 = not selected, 1= selected), and FBS levels ≥
100mg/dl 0= No, 1=Yes).
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The results of the test were interpreted using a p-value ≤ 0.05. Cross-tabulation is
one of the simplest ways to analyze the relationships between variables (Wagner, 2017).
The results for RQ1 and RQ2 were presented as frequencies/counts.
RQ1
I explored the prevalence of previously documented metabolic risk factors for
abnormal obesity measures amongst a representative sample of the Tobago adult
population. First, I carried out cross-tabulation analysis on independent the variable
abnormal obesity measures/ABOMEASU which are valued as 0 = No and 1=Yes was
carried out. The dependent variables are metabolic risk factors FBS levels ≥ 100mg/dl
and blood pressure range ≥ 130/85 mm Hg, defined by IDF criteria for MetS. Binary
values are used for FBS ≥ 100mg/dl / BSHIGH_2) (0=No and 1=Yes), and blood
pressure range ≥130/85/HYPERTEN2 (0= not selected and 1= selected).
Fasting Blood Sugar
There were 61.9% (n=167) participants with FBS levels ≥ 100mg/dl. However,
64.4% (n=94) of those participants had both abnormal obesity measures with FBS levels
≥ 100mg/dl. Chi-square test for association was conducted between FBS levels ≥
100mg/dl and the abnormal obesity measures. There was no statistically significant
difference between abnormal obesity measures with FBS levels ≥ 100mg/dl (χ2 (1, N =
270) = 0.86, p = 0.35).
I explored each abnormal obesity measure such as BMI, WC, and WHR to
establish whether there was a relationship with FBS levels ≥100mg/dl. A total of 64.1%
had elevated BMI greater than 30kg/m ² with FBS levels ≥ 100mg/d (see Table 7). This
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result was not statistically significance (χ2 [1, N = 270] = 0.63, p = 0.43). Cross
tabulation analysis showed a proportion, 63.5% of the sampling population with FBS
levels ≥100mg/dl, also had an abnormal WC. This result was not statistically significance
(χ2 [1, N = 270] = 1.46, p = 0.23). Cross tabulation and chi-square analysis were
performed on WHR, 70.2% of the population with elevated FBS levels ≥100mg/dl had
abnormal WHR. In comparison to the other two obesity measures, there was statistically
significance with having elevated FBS levels ≥100mg/dl along with an abnormal WHR
(χ2 [1, N= 270] = 4.99, p=0.03. Cramer’s V test showed the strength of the relationship
was weak for having an abnormal WHR with fasting blood glucose level ≥ 100mg/dl
(Cramer’s V = 0.14, Table 8). However, according to Gauer et al. (2016), a Cramer’s V
value of 0.1 to 0.2 indicated a weak relationship.
Table 7
Prevalence of Fasting Blood Sugar ≥100mg/dl and Abnormal Obesity Measures Based
on Gender
Variables

Male participants Female
participants

Total
participants

Fasting Blood Sugar
≥100mg/dl and abnormal
obesity measures
Fasting Blood Sugar
≥100mg/dl and abnormal
WHR
Fasting Blood Sugar
≥100mg/dl and abnormal
WC
Fasting Blood Sugar
≥100mg/dl and normal
BMI ≥30kg/m2

17 (58.6%)

77(65.8%)

94(64.4%)

16(69.6%)

57(70.4%)

73(70.2%)

23(54.8%)

118(65.6%)

141(63.5%)

16(57.1%)

75(65.8%)

91(64.1%)
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Table 8
Abnormal Obesity Measures Based on Gender
Variables

Fasting Blood Sugar
≥100mg/dl and
abnormal obesity
measures
Fasting Blood Sugar
≥100mg/dl and
abnormal WHR
Fasting Blood Sugar
≥100mg/dl and
Fasting Blood Sugar
≥100mg/dl and
abnormal WC
Fasting Blood Sugar
≥100mg/dl and
normal BMI
≥30kg/m2

Male
participants
χ2, p values
0.52, 0.47

Female
participants
χ2, p values
0.09, 0.77

Total
participants
χ2, p values
0.86, 0.35

Cramer’s
V

3.52, 0.06

1.76, 0.19

4.98, 0.03*

0.14*

0.07, 0.79

0.31, 0.58

1.46, 0.23

0.25, 0.62

0.08, 0.78

0.63, 0.43

Hypertension
In comparison to fasting blood sugar, fewer participants (51.4%) self-reported on
having a blood pressure range ≥130/85 mmHg, and also having abnormal obesity
measures (Table 9). Chi-square test for association performed on the three independent
variables and blood pressure range ≥130/85 mmHg, the results indicated that there was
no significant association with having a blood pressure range ≥130/85 mm Hg and
having abnormal obesity measures (χ2 [1, N = 270] = 1.64, p = 0.20).
Similar to the analytical procedure performed for fasting blood sugar levels, I
used Chi-square test for association to establish whether there was a relationship with
having a blood pressure range ≥130/85 mm Hg with abnormal obesity measures: BMI,
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WC, and WHR. A total of 52.1% had elevated BMI greater than 30kg/m ² with blood
pressure range ≥130/85 mm Hg (Table 9). This result was not statistically significant (χ2
(1, N = 270) = 2.26, p = 0.13). A smaller proportion of 47.7% of the sampling population
with blood pressure range ≥130/85 mm Hg, also had an abnormal WC. This result was
not statistically significant (χ2 [1, N = 270] = .00, p = 0.98). Cross tabulation and chisquare analysis were conducted on WHR, 48.1% of the population with blood pressure
range ≥130/85 mm Hg, also had abnormal WHR. The chi-square test for association was
not statistically significant with having blood pressure range ≥130/85 mm Hg with an
abnormal WHR (χ2 [1, N = 270] = 0.01, p = 0.94, Table 10).
Finally, in reference to RQ1, although, there was statistical significance in
dependent variables FBS levels ≥100mg/dl with independent variable, abnormal WHR
(χ2 [1, N =270] = 0.4.99, p = 0.03). The relationship was weak (Cramer’s V value =
0.14). Taking in consideration that all other p-values for the sampling population were
above the significance threshold value of ≥.05. I failed to accept the alternative
hypothesis, that there is a prevalence of previously metabolic risk factors for abnormal
obesity measures amongst Tobago adult population.
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Table 9
Prevalence of Elevated Blood Pressure ≥130/85mm Hg and Abnormal Obesity Measures
Based on Gender
Variables
Blood Pressures
≥130/85mmHg and
abnormal obesity measures
Blood Pressure
≥130/85mmHg and
abnormal WHR
Blood Pressure
≥130/85mmHg and
abnormal WC
Blood Pressure
≥130/85mmHg and normal
BMI ≥30kg/m2

Male participants Female
participants
17 (58.6%)
58 (49.6%)

Total participants

14 (60.9%)

36(44.4%)

50(48.1%)

31(73.8%)

75(41.7%)

106(47.7%)

16(57.1%)

58(50.9%)

74(52.1%)

75 (51.4%)

Table 10
Chi-Square Analysis for Elevated Blood Pressure ≥130/85mm Hg and Abnormal Obesity
Measures Based on Gender
Variables

Male
participants
χ2, P-values
0.70, 0.40

Blood Pressure
≥130/85mmHg and
abnormal obesity
measures
Blood Pressure
0.18, 0.67
≥130/85mmHg and
abnormal WHR
Blood Pressure
3.83, 0.05*
≥130/85mmHg and
abnormal WC
Blood Pressure
1.03, 0.31
≥130/85mmHg and BMI
≥30kg/m2

Female
participants
χ2, P-values
7.49, 0.01*¹

Total
participants
χ2, P-values
1.64, 0.20

0.45, 0.50

0.01, 0.94

0.00, 0.97

0.00, 0.98

9.53, 0.00*

2.26, 0.13

Cramer’s
V
0.20*
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RQ2
How prevalent metabolic risk factors for abnormal obesity measures differ by
gender within the Tobago adult population. The related null hypothesis (was: There is no
difference with the prevalence of metabolic risk factors for abnormal obesity measures by
gender within the Tobago adult population. Crosstabulation was performed, and chisquare tests on categorical data to determine the prevalence of abnormal obesity measures
with FBS levels ≥ 100mg/dl and blood pressure range ≥ 130/85 mm Hg stratified by
gender. Abnormal obesity measures (BMI, W.C., and WHR) were examined with each
dependent variable. The dependent variable metabolic risk factors were analyzed using
binary values FBS/ BSHIGH_2, 0=No, and 1=Yes), and blood pressure range
≥130/85/HYPERTEN2 (0= not selected and 1= selected). The independent variables
abnormal obesity measures, WC/WAIST_1 and WHR/ WHR_1 used binary levels 1 =
Yes and 0 = No. BMI/BMI_2 was categorized into the follow groups: 1 = Underweight, 2
= Normal weight, 3 = Overweight and 4 = Obese. To account for the gender difference,
gender was categorized as 1= male and 0 = female.
Fasting Blood Sugar
The results from cross-tabulation analysis showed that a larger proportion of
female participants in comparison to male counterparts self-reported on having abnormal
obesity measures with FBS levels ≥ 100mg/dl, 65.8% versus 58.6%. However, for chisquare test for association result were not statistically significant for both male (χ2 [1, N
= 270] = 0.52, p = 0.47) and female (χ2 [1, N = 270] = 0.89, p = 0.77) respectively.
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Cross tabulation and chi-square analysis carried out for each abnormal obesity
measures (BMI, WHR, and WC) when controlling for the confounding factor of gender.
Results showed a larger proportion of female self-reported on having three abnormal
obesity measures with FBS levels ≥ 100mg/dl (Table 9). A total of 65.5% of females had
BMI greater than 30kg/m ² versus 57.1% males. Similarly, 65.5% females, as compared
to 54.8% males had elevated WC, and 70.2% females versus 69.6% males had elevated
WHR along with FBS levels ≥ 100mg/dl. Each abnormal obesity measures showed no
significant relationship with having with FBS levels ≥ 100mg/dl for both males and
females (see Table 10).
Hypertension
Unlike the result for FBS, the result from crosstabulation analysis for selfreported blood pressure range showed that a greater proportion of male participants in
comparison to their female counterparts self-reported on having abnormal obesity
measures with blood pressure range ≥ 130/85 mm Hg, 58.6% versus 49.6%. Cross
tabulation analysis carried out for each abnormal obesity measures (BMI, WHR, and
WC) according to gender. More males self-reported a BMI ≥ 30kg/m ² along with blood
pressure range ≥ 130/85 mm Hg, that is, 57.1% males versus 50.9% female. Similarly,
more males 73.8% compared to 41.7% female had elevated WC along with blood
pressure range ≥ 130/85 mm Hg. Also, 60.9% of male versus 44.4% females had elevated
WHR along with blood pressure range ≥ 130/85 mm Hg. Statistical significance was
found for females having blood pressure range ≥ 130/85 mm Hg with BMI range
≥30kg/m² (Table 10). A Cramer’s V test was performed to evaluate the strength of the
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relationship. However, the effect was small. These findings suggest that though
significant, abnormal obesity measures (WC and BMI) have a small effect on blood
pressure range ≥ 130/85 mmHg for females and males, respectively. According to these
findings for metabolic risk factors and abnormal obesity measures according to gender,
the null hypothesis for RQ 3 can be rejected.
RQ3
What is the relationship, if any, in obesity abnormal measures and metabolic risk
factors for males and females within the ages of 18 to 60 years in Tobago? The related
null hypothesis was: There is no relationship between abnormal obesity measures and
metabolic risk factors for males and females within the ages of 18 to 60 years in Tobago.
Pearson correlation was initially proposed to examine the relationship between
abnormal obesity measures and metabolic risk factors for males and females for the data
analysis plan. The continuous variables of obesity measures (BMI, WHR, and W.C.) and
metabolic risk factors (SBP, DBP, and FBS) were tested for linearity using scatterplots.
In contrast, histogram and Q-Q plots were used to assess the normality of the data. The
data were positively skewed and violated the assumptions of the Pearson correlation
coefficient. To carry out analysis for R.Q. 3, a nonparametric test was used, Pearson chisquare, to examine the relationship of obesity measures and metabolic risk factors
stratified by gender, using categorical data. Abnormal obesity measures were analyzed as
a single variable, valued as 0= No and 1= Yes. At the same time, each metabolic risk
factor (FBS levels ≥100mg/dl and blood pressure range ≥ 130/85 mm Hg) was also
valued as 0 = No and 1= Yes. To account for the gender difference, gender was
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categorized as 1= male and 0 = female. The relationship was considered significant at a
p-value ≤ of 0.05. The strength of the relationship was examined using Cramer’s V of
association. Cramer’s V measure of association ranges from 0 to 1, showing damaging to
positive strength (Gauer et al., 2016). A Cramer’s V value of 0.1 to 0.2 is considered a
weak association, while 0.2 to 0.3 is moderate, and a value above 0.3 is a strong
relationship (Gauer et al., 2016).
Evaluating the relationship between abnormal obesity measures with a blood
pressure range ≥ of 130/85 mm Hg by gender shows a prevalence of 58.6% males and
49.6% females have both abnormal obesity measures with a blood pressure range ≥ of
130/85 mm Hg (Table 10). There was a significant association between abnormal obesity
measures with a blood pressure range ≥ 130/85 mm Hg for female participants (χ2 (1, N
=270) = 7.49, p=0.01). However, although the relationship was positive for female,
having a Cramer’s V value of 0.20 suggest a weak relationship (seeTable 10).
Comparatively, crosstabulation analysis showed females were likely to have
abnormal obesity measures with fasting blood sugar ≥ 100mg/dl than the male samples,
65.8% and 58.6%, respectively. Similarly, Pearson chi-square test results did not show
any association between male and female participants having abnormal obesity measures
and fasting blood sugar ≥ 100mg/dl (χ2= [1, N =270] =0.52, p = 0.47 and χ2 (1, N= 270)
= 0.89, p =0 .77, respectively. The relationship between having an abnormal obesity
measure with fasting blood sugar ≥ 100mg/dl according to gender was not significant
(Table 10).
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These results indicate a negligible effect on the relationship between metabolic
risk factors and abnormal obesity measures stratified by gender. According to these
findings, the null hypothesis for R.Q. 3 can be rejected.
RQ4
In what way abnormal obesity measures including BMI, W.C., and WHR
predicted metabolic risk factors among a representative sample of the Tobago adult
population. The related null hypothesis was: Abnormal obesity measures including body
mass index, waist circumference, and waist-to-hip ratio do not predict metabolic risk
factors among a representative sample of the Tobago adult population.
A logistic regression model was used to test this hypothesis. Petersen and
Deddens (2008) found that the logistic regression model is suitable to identify the ratio of
odds within prevalence studies. Binary logistic regression analysis was commuted on
individual abnormal obesity measures: WHR, W.C., and BMI to predict the outcome of
metabolic risk factors, B.P. range ≥ 130/85mm Hg and FBS ≥ 100mg/dl. The assumption
of using the binary logistic regression method was not violated by having a definite
outcome. The dependent variable metabolic risk factors were analyzed using binary
values FBS/ BSHIGH_2 (0=No and 1=Yes), and blood pressure range
≥130/85/HYPERTEN2 (0= not selected and 1= selected). The independent variables
WC/WAIST and WHR/WHRATIO were measured as continuous variables, while
BMI/BMI_2 was measured as a categorical variable: 1 = Underweight, 2 = Normal
weight, 3 = Overweight, and 4 = Obese. Using binary logistic regression, I created a
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model that best fit the data and differentiated the occurrences of metabolic risk factors
among the sampling population.
Each abnormal obesity measure, BMI, W.C., and WHR, was explored to predict
the sampling population having B.P. range ≥ 130/85 mmHg. Hosmer and Lemeshow’s
test showed that the model adequately fit sample data and the population from which the
sample was collected. The p-value of the Hosmer and Lemeshow test was 0 .79
(insignificance p > .05), indicating the model fits the data well (Abedin et al., 2016). The
results found that none of the three independent variables were significant predictors or
the odds of participants having a blood pressure range ≥ 130/85mm Hg (Table 11). Each
independent variable (WHR, W.C., and BMI ≥30kg/m2) had alpha values greater than
0.05. Hence, there is insufficient evidence to support BMI, W.C., and WHR have a
significant relationship or effects on having a BP≥ 130/85 mmHg.
Table 11
Binary Logistic Regression Analysis for the Occurrence of Metabolic Risk Factors, BP
Range ≥ 130/85mm Hg Predicted by Obesity Measures of WHR, WC and BMI ≥ 30 kg/m²
Variables
BMI ≥30kg/m²

B
-0.29

SE
0.36

Wald
0.65

df
1

P
0.42

OR
0.75

95% CI
Lower
0.37

WC

0.00

0.02

0.00

1

1.00

1.00

0.97

1.04

WHR

2.16

2.42

0.80

1

0.37

8.67

0.08

988.99

Upper
1.51

Constant
-1.77
1.69
1.10
1
0.29
0.17
Note. Full model: χ2 (5, N = 270) = 4.76, p = 0.45. Initial classification overall rate =
52.2%. Final correct classification overall rate = 54.1%.
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Binary logistic regression analysis was conducted to investigate whether BMI
≥30kg/m², WC, WHR were factors which predict FBS level ≥ 100mg/dl. The outcome of
interest was FBS ≥ 100mg/dl. While the possible predictors were BMI ≥30kg/m², WC,
WHR. The Hosmer- Lemeshow goodness of fit was not significant (p > .05), indicating
that the model is correctly specified. The (-2 log Likelihood = 352.03) and (Nagelkerke R
Square = 0.03). The model showed that the independent variables BMI ≥30kg/m² and
WC were not significant, p = 0.37 and p = 0.50, respectively (p > 0.05), see Table 12).
However, controlling for BMI ≥30kg/m² and WC, the predictor variable, WHR in
the logistic regression analysis was found to contribute positively to the model. The
unstandardized B = [5.06], SE = [2.52] Wald = [4.04], p = 0.05. The estimated odds ratio
favored a positive relationship for WHR of almost 157 times (Exp [B] = 157.37, 95% CI
[1.13 – 21875.75]) for every one unit increase in participants WHR. Based on statistical
significance, I will reject the null hypothesis that abnormal obesity measures including
BMI, WC, and WHR do not predict metabolic risk factors among a representative sample
of the Tobago adult population.
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Table 12
Binary Logistic Regression Analysis for the Occurrence of Metabolic Risk Factors, FBS
≥ 100mg/dl, Predicted by Obesity Measures of WHR, WC and BMI ≥ 30 kg/m²
Variables
BMI
≥30kg/m²
Abnormal
WC
Abnormal
WHR
Constant

B
-0.34

SE
0.37

Wald
0.82

df
1

P
0.37

OR
0.72

95% CI
Lower
Upper
0.35
1.48

-0.01

0.02

0.46

1

0.50

0.99

0.95

5.06

2.52

4.04

1

0.05

157.37 1.13

-2.43

1.75

1.94

1

0.16

0.09

1.03
21875.75

Note. Full model: χ2 (5, N = 270) = 6.95, p =0.22. Initial classification overall rate =
61.9%. Final correct classification overall rate = 62.2%.
Post Hoc Analysis on Behavior Risk Factors
In order to provide a theoretical understanding on factors which contribute to
metabolic risk factors and abnormal obesity measures, as part of the data collection
procedure, participants self-reported on behavior risk factors. To further explore these
factors which were not the primary objective of this study, I carried out post hoc analysis
to examine whether BMI, WHR, WC, dietary habits, and physical activity predicts
metabolic risk among participants. Binary logistic regression analysis was used to carry
out the post hoc analysis. The outcome variables of interest were metabolic risk factors,
BP range ≥ 130/85mm Hg and FBS ≥ 100mg/dl. The possible predictors were WHR,
WC, BMI, how often did you drink sugar-sweetened fruit drinks during the past 30
days/SUGADRINKS; physical activities/PA; and are your watching your salt
intake/WTCHSALT. The dependent variable metabolic risk factors were analyzed using
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binary values FBS/ BSHIGH_2) (0=No and 1=Yes), and blood pressure range
≥130/85/HYPERTEN2 (0= not selected and 1= selected). The independent variables
BMI, WC/WAIST, and WHR/WHRATIO were measured as continuous variables for this
analysis; how often did you drink sugar-sweetened fruit drinks during the past 30
days/SUGADRINKS were categorical variable: (1 =Never, 2 = 1-7 days, 3 = 8 to 14
days, 4 = 15 to 21 days, 5 = greater than 21 days); physical activities/ PA were measured
in two categories: (0 = No and 1 = Yes); and are your watching your salt intake: (0 = No
and 1 = Yes).
When using BP range ≥ 130/85mm Hg as the outcome variable, the Hosmer and
Lemeshow goodness of fit tests showed that the model adequately fit sample data, and
also for the population from which the sample was collected. The p-value of Hosmer and
Lemeshow test = χ2 (8, N = 270) = 13.59, p = 0.09 (insignificance p > .05), indicating the
model fits the data well (Abedin et al. 2016). The (-2 log Likelihood = 328.27) and the
(Nagelkerke R Square test =0.07). This model was able to predict participants with BP
range ≥ 130/85mm Hg compared to those who do not, 74.4% versus 45.6%. An overall of
61.1% of the 270 participants were correctly classified (see Table 13).
Similarly, when using FBS ≥ 100mg/dl as an outcome variable for metabolic risk
factor, the Hosmer and Lemeshow goodness of fit tests indicated that the model
adequately fit sample data. The p-value of Hosmer and Lemeshow test = χ2 (8, N = 270)
= 6.51, p = 0.59 (insignificance p > .05), again signifying that the model fits the data
well. The (-2 log Likelihood = 323.32) and the (Nagelkerke R Square test =0.04). This
model was able to predict participants exposed to FBS ≥ 100mg/dl compared to those
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who do not, 93.4% versus 12.5%. An overall of 61.9% of the sample population (N=270)
were correctly classified (see Table 14).
Results showed that none of the five independent variables were significant
predictors of having each metabolic risk factors: blood pressure range ≥ 130/85mm Hg
and FBS ≥ 100mg/dl. Each independent variable had alpha values greater than 0.05.
Therefore, there were insufficient evidence to support that variables BMI, WC, WHR,
SUGADRINKS, WTCHSALT, and PA have any significant relationship or effects on
either BP≥ 130/85mm Hg or FBS ≥ 100mg/dl (see Table 13 & 14). I failed to reject the
null hypothesis that abnormal obesity measures including BMI, WC, and WHR do not
predict metabolic risk factors among a representative sample of the Tobago adult
population.
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Table 13
Binary Logistic Regression Analysis for the Occurrence of Metabolic Risk Factors, BP≥
130/85mm Hg, Predicted by WHR, WC BMI, Physical Activity Pattern, Salt Intake, and
Sugar-Sweetened Drink Consumption
95% (C.I .)
Variables
BMI
WC

B
-0.02
0.02

S.E.
.039
.024

Wald
0.37
0.54

df
1
1

Sig
0.54
0.46

Exp (B)
0.98
1.02

Lower
.90
.97

Upper
1.05
1.07

WHR

0.78

2.69

0.08

1

0.77

2.17

0.01

425.43

Physical Activities
Are your watching
your salt intake?

-0.53
0.00

0.30
.279

3.24
.000

1
1

0.07
1.00

0.59
1.00

0.33
0.58

1.05
1.73

5.847

4

How often do you
drink sugarsweetened drinks in
30 days
How often do you
drink sugarsweetened drinks in
30 days (1)
How often do you
drink sugarsweetened drinks in
30 days (2)
How often do you
drink sugarsweetened drinks in
30 days (3)
How often do you
drink sugarsweetened drinks in
30 days (4)
Constant

-0.35

0.35

0.98

1

0.32

0.71

0.36

1.41

-.722

.360

4.024

1

.05

.486

.240

.984

-.838

.467

3.221

1

.073

.433

.173

1.080

-.797

.635

1.574

1

.210

.451

.130

1.566

-.967

1.819

.283

1

.595

.380

Note: Full Model: χ² = (10, N = 270) =12.76, P = 0. 24. The overall classification ranged from 54.2.% to
59.0%.
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Table 14
Binary Logistic Regression Analysis for the Occurrence of Metabolic Risk Factors, FBS
≥ 100mg/dl, Predicted by WHR, WC BMI, Physical Activity Pattern, Salt Intake, and
Sugar-Sweetened Drink Consumption
95% (C.I.)
Variables
BMI
WC
WHR

B
-0.01
-0.02
3.67

S.E.
0.04
.024
2.73

Wald
0.23
0.01
1.08

df
1
1
1

Sig
0.88
0.94
0.18

Exp (B)
0.99
1.00
39.27

Lower
0.92
0.95
0.19

Physical Activities
Are your watching
your salt intake?
How often do you
drink sugarsweetened drinks in
30 days
How often do you
drink sugarsweetened drinks in
30 days (1)
How often do you
drink sugarsweetened drinks in
30 days (2)
How often do you
drink sugarsweetened drinks in
30 days (3)
How often do you
drink sugarsweetened drinks in
30 days (4)
Constant

-0.37
-0.18

0.31
0.28

1.45
0.42

1
1

0.23
0.52

0.69
0.83

0.38
0.48

Upper
1.07
1.05
8320.5
6
1.26
1.44

0.89

4

0.93

0.18

0.36

0.24

1

0.62

1.20

0.59

2.43

-0.06

0.36

.03

1

0.86

0.94

0.42

1.90

-0.15

0.46

0.102

1

0.75

0.86

0.35

2.14

-0.25

0.62

1.65

1

0.68

0.78

0.23

2.63

-1.79

1.85

0.94

1

0.33

0.17

Note. Full model: χ2 (10, N = 270) =8.34, p = 0. 60. The overall classification ranged from 61.4% to 63.3%.
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Summary and Transition
In this cross-sectional and quantitative investigation, I examined the evidence of
metabolic risk factors amongst the Tobago adult population, and also investigated
whether there was a correlation between abnormal obesity measures and metabolic risk
factors among Tobago adults, ages 18 to 60 years. For the study, I used a self-reported
questionnaire to collect data. The IDF diagnostic criterion for MetS used to define
abnormal obesity measures and metabolic risk factors according to gender specific.
A total of 270 participants met the criteria for the study, 197 females and 73
males. Descriptive statistics used to analyze participants’ demographics, obesity
measures, metabolic risk factors, and behavior risk factors, although the main emphasis
was obesity measures and metabolic risk factors. Inferential statistics such as crosstabulation, chi-square, and binary logistic regression analysis were used to test four
research questions and supporting hypotheses.
For RQ1, contingency table and chi-square analysis were used to determine the
prevalence of previously documented metabolic risk factors for abnormal obesity
measures amongst a representative sample of the Tobago adult population. The results for
RQ1 showed more participants had FBS ≥ 100mg/dl along with abnormal obesity
measures, that is, 64.4% whilst 51.4% of participants had their BP≥130/85 mm Hg with
abnormal obesity measures. The p values for both metabolic risk factors along with
abnormal obesity measures were above the >.05 criterion for statistical significance. For
RQ1, I failed to reject the null hypothesis that there was no prevalence of previously
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documented metabolic risk factors for abnormal obesity measures amongst the Tobago
adult population.
RQ2 determines how prevalent metabolic risk factors for abnormal obesity
measures differ by gender among the sampling population. The result for RQ2 showed
that the prevalence of metabolic risk factors: FBS ≥ 100mg/dl along with abnormal
obesity measures were higher among female than male participants, FBS: 65.8%% versus
58.6% respectively. In contrast, having blood pressure level ≥ 130/85 mm Hg with
abnormal obesity measures were higher among men than women participants, 58.6%
versus 49.6%. Chi square test was used to determine how prevalent metabolic risk factors
for abnormal obesity measures differ by gender among the sampling population. There
was statistical significance found for females having ≥ 130/85 mm Hg along with
abnormal obesity measures. Based on statistical significance, I reject the null hypothesis
that there is no difference with the prevalence of metabolic risk factors for abnormal
obesity measures by gender within Tobago adult population.
RQ 3 dealt with whether a relationship existed between obesity abnormal
measures and metabolic risk factors for the males and females. A larger proportion of
males in comparison to females had abnormal obesity measures with blood pressure
range ≥ 130/85 mm Hg. There was statistical significance of having blood pressure range
≥ 130/85 mm Hg along with BMI ≥30kg/m2 for female participants. Cramer’s V test
showed that the strength of this effect was small. However, contrary to these findings,
more female participants had fasting blood sugar levels ≥ 100mg/dl along with abnormal
obesity measures than their male counterparts. There was no statistical significance found
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with having fasting blood sugar levels ≥ 100mg/dl with abnormal obesity measures (p
values >0.05). Based on statistical significance, I reject the null hypothesis that a
relationship exists between obesity abnormal measures and metabolic risk factors for the
males and females.
For RQ4, a binary logistic regression model was used to examine the way in
which abnormal obesity measures including BMI, WC, and WHR predicts metabolic risk
factors among a representative sample. With regards to FBS level ≥ 100mg/dl, the
estimated odd ratio favored a positive relationship for WHR. Based on statistical
significance, I will reject the null hypothesis that abnormal obesity measures including
BMI, WC, and WHR do not predict metabolic risk factors among a representative sample
of the Tobago adult population.
To further scrutinize factors which may most likely have an impact on metabolic
risk factors, I carried out post hoc analysis to include behavior risk factor within the
regression model to predict metabolic risk among participants. However, there was
insufficient evidence to support BMI, WC, WHR, SUGADRINKS, WTCHSALT, and
PA have any significant relationship or effects on either BP≥ 130/85mm Hg or FBS ≥
100mg/dl.
In Chapter 5, I provided a brief introduction, an interpretation of the result and
compared it with the findings found in peer-reviewed literature and in the context of the
theoretical framework. In Chapter 5, I highlighted the strength and limitations of the
study, along with recommendations for future research. Finally, I presented the
implication of social change.
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Chapter 5: Discussion, Recommendation, and Conclusion
The objectives of this quantitative study were to assess whether there is evidence
of metabolic risk factors amongst the Tobagonian adult population and to determine
whether there is correlation between abnormal obesity measures and metabolic risk
factors among Tobagonian adults age 18 to 60. In this chapter, I provide interpretations of
the findings, limitations of the study, recommendations, implications for social change,
and a conclusion.
Interpretation of the Findings
To recognize metabolic risk factors and obesity measures, I used the MetS
definition to identify the criteria for this study, as defined by the IDF, WHO, NCEP-ATP,
NHLBI, and the American Association of Clinical Endocrinologists (see IDF, 2006;
Moore et al., 2017; Muñoz et al., 2013). The cutoff points for an abnormal WC were ≥ 94
cm for men and ≥ 80 cm for women (see Nolan et al., 2017). The WHO criteria for WHR
were > 0.90cm and > 0.85cm for men and women, respectively, and the BMI criteria
were ≥ 30 kg/m² (see Aynalem & Zeleke, 2018; Khorrami et al., 2017; Kyrkou et al.,
2016; Moore et al., 2017). These definitions provided measures to identify two metabolic
risk factors: elevated systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg, and elevated fasting
blood sugar ≥ 100 mg/dl (see Alberti et al., 2005; IDF, 2006; Parikh & Mohan, 2012).
Prevalence of Abnormal Obesity Measures
Researchers evaluated the prevalence of obesity using BMI, but other measures
such as WC and WHR are also significant indicators to determine associated health risks
(Hulsegge et al., 2017; Jacobsen & Aars, 2016; Rahmani et al., 2014; Swainson et al.,
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2017). Some researchers reiterated the importance of including both general and
abdominal obesity to assess for cardiometabolic risk (Castillo et al. 2015; Sebo et al.,
2017). Fat distribution was significantly associated with cardiovascular risk (Castillo et
al. 2015; Sebo et al., 2017). In the current study, I recognized that abnormal obesity
measures including WC, WHR, and BMI are present with metabolic risk factors.
Osei-Yeboah et al. (2017) stated that WC is the most acceptable anthropometric
index to identify central obesity and MetS according to the NCEP ATP III and the IDF. I
found that 82.2% of the sample population had an abnormal WC, 52.6% had a BMI ≥
30kg/m², and 38.5% had an abnormal WHR according to the outlined cutoff values.
These findings were consistent with a recent study by Solomon et al. (2020), in which
abnormal WC was the most prevalent obesity measure among the urban Black population
in South Africa based on the assessment of the association of dietary adherence,
anthropometric measurements, and blood pressure. Solomon et al. reported a slightly
higher prevalence in WC among the studied population (85%) when compared to the
present study. Solomon et al. reported that 76% had abnormal BMI and 64% had an
abnormal WHR. Because central obesity is related to the inflammatory response
mechanism and insulin resistance is a key predictor of T2DM risk (Ming-Kuo et al.,
2018), the high prevalence of abnormal WC found in the current study and other studies
warrants robust public health intervention.
In the current study, gender dominance was noticeable in the recognition of
abnormal obesity measures, as women were more likely to have abnormal obesity
measures than men (57.9% versus 38.4%). For each obesity measure used, women had a
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higher chance of having abnormal measurements than men. A total of 41.1% of women
versus 31.5% of men had an abnormal WHR, 91.4% of women versus 57.5% of men had
an abnormal WC, and 57.9% of women versus 38.4% of men had a BMI ≥ 30kg/m².
These findings corroborated the results of other studies, which indicated females were
more likely than males to be categorized as obese and to have abnormal WC, WHR, and
BMI. A few researchers examined a diverse population and reported similar findings that
abnormal WC is more prevalent among females than males (Camila Maciel et al., 2020;
Hu et al., 2017, Solomon et al., 2020). However, these findings were not supported by
Castillo et al. (2015) who reported that men were more likely to have an abnormal WHR
than women (p < .05).
Prevalence of Metabolic Risk Factors
The current study results suggested that metabolic risk factors were prevalent
among the Tobagonian working class population. A total of 63.3% of the sample
population self-reported as having a systolic blood pressure level ≥ 130mm Hg, while
59.6% had a diastolic level ≥ 85mm Hg. However, a smaller portion of participants had
an elevated blood pressure range (47.8%) compared to those having an elevated fasting
blood sugar range (61.9%). The prevalence of high blood pressure was slightly higher
than a previous retrospective database survey conducted by the Ministry of People and
Social Development in T&T (MOH, 2017). This study included a larger sample
population of 14,793 but reported a lower prevalence (30.4%) of self-reported
hypertension (MOH, 2017).
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Regarding gender inequality, the findings of the current study are comparable to
those from other studies that found that males (64.4%) are more likely to have an
elevated blood pressure range in comparison to females (41.6%). Chor et al. (2015) found
an increased prevalence of high blood pressure among Brazilian males (40.1%) in
comparison to females (33.2%). In contrast to these findings that were gender specific,
there were reverse interpretations in the Chadee et al. (2013) study, which was carried out
among the T&T population. Chadee et al. examined the prevalence of self-reported
diabetes, hypertension, and heart disease and compared findings with the PAHO/WHO
National STEPS Survey (2011) in T&T. Chadee et al. recognized that gender specifics
also played a significant role in the PAHO/WHO National STEPS Survey and observed
that the increased prevalence of self-reported hypertension was more substantial among
women than men by 8%.
Diabetes is the other metabolic risk factor found to have serious health
consequences, and it is a major contributor to premature mortality for the populace of
T&T (Sobers-Grannum et al., 2015). Investigators examined the prevalence of diabetes
within T&T, and by extension the Caribbean. Sobers-Grannum et al. (2015) estimated
that 10–15% of the Caribbean population is affected by diabetes. The MOH (2015) in
T&T highlighted a national prevalence of 14.5%, while the PAHO/WHO National
STEPS Survey observed a slightly higher prevalence of 20.5% for self-reported elevated
fasting blood sugar levels during the chronic noncommunicable risk factor survey.
However, in the present study, a higher prevalence of 47.8% was self-reported among the
sampling population on elevated fasting blood sugar. Similarly, female dominance was
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significant in this study, where a higher prevalence of women (65%) self-reported an
abnormal fasting blood sugar than their male counterparts (53.4%).
Other researchers recognized gender differences as a significant component to
characterize metabolic risk factors including diabetes (Beigh & Jain, 2012). The findings
from the present study were consistent with results of Sorbers-Grannum et al. (2015) who
conducted a systematic review and meta-analysis within the Caribbean to investigate
social determinants of diabetes. Sorbers-Grannum et al. found a higher prevalence of
diabetes among women than men in nine of the articles reviewed. However, SorbersGrannum et al. recognized that two studies were not statistically significant.
Identification of Metabolic Syndrome
In the current study, the application of obesity parameters WC, BMI, and WHR
were easy to use and were suitable to predict and recognize the prevalence of abnormal
obesity measures with metabolic risk factors among the studied sample. Having a cluster
of these metabolic risk factors that include central obesity, hypertension, hyperglycemia,
and dyslipidemia defines MetS (Mirmiran et al., 2014). The IDF recognized that central
obesity and two other risk factors were key elements in the identification of the MetS
(Nolan et al., 2017).
The prevalence of central obesity was 82.2% among the current study’s sample
population. There was a larger portion of women with abnormal WC (91.4%) in
comparison to men (57.5%). Findings also showed that 38.3% had three factors as
classified by the IDF definition for MetS. These risk factors were abnormal WC ≥ 94 cm
for men and ≥ 80 cm for women, along with increased blood pressure systolic BP ≥ 130
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and diastolic BP ≥ 85 mm Hg and increased fasting blood glucose ≥ 100 mg/dL (Nolan et
al., 2017). Although the Enzawaka et al. (2009) study was conducted more than 5 years
ago, their findings were comparable to the present study because they used a similar
population and examined the prevalence of MetS in 166 Tobagonians. Among the same
population, Enzawaka et al. reported a slightly higher portion (83.7%) of abnormal WC,
and 48.4% of their participants had abnormal WC with two other metabolic components
according to IDF criteria. Although the Tobagonian population shares similar MetS
characteristics to many countries, there were limited evidence-based publications on the
overall prevalence rate of MetS and its components. Both sets of findings show the
usefulness of the IDF definition in recognizing the prevalence of MetS among the
Tobagonian population.
Relationship of Obesity Measures and Metabolic Risk Factors
The connection between obesity measures and metabolic risk factors has been
well established in the literature and was addressed in the current investigation.
Ezenwaka et al. (2008) forecasted projection in cardiovascular and diabetes disease due
widespread prevalence of MetS throughout T&T. In the present study, such prevalence
was also noticeable among the Tobagonian population, in which 64.4% of the sample
population had fasting blood sugar ≥ 100mg/dl with abnormal obesity measures while
51.4% had blood pressure range ≥ 130/85 mm Hg with abnormal obesity measures.
In addition, the prevalence rate was higher for BMI ≥ 30 kg/m² with elevated
fasting sugar (64.1%) than with elevated blood pressure (57.4%). The prevalence (52.1%)
was higher for BMI ≥ 30 kg/m² with elevated blood pressure among the sample
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population. Having abnormal WC was associated with elevated blood pressure in this
study. On the other hand, abnormal WHR was strongly associated with either elevated
fasting blood sugar or elevated blood pressure. These findings were not comparable with
Mirmiran et al. (2014) who found that BMI was the best predictor to detect hypertension
when the association of MetS and obesity measures was examined among Tehranian
adolescents. Despite the high prevalence rate of obesity measures with metabolic risk
factors among the sample population, WC, WHR, and BMI were insignificant predictors
for blood pressure range ≥ 130/85 mm Hg, and WHR was the only significant predictor
to FBS level ≥ 100mg/dl.
Gender inequality was quite noticeable in the prevalence of MetS (Beigh & Jain,
2012; S. Lee et al., 2016). Due to the limited scientific evidence conducted on the
Tobagonian population, it is feasible to refer to the study by Ezenwaka et al. (2007) that
included a small sample of the Tobagonian population to compare the prevalence of
MetS and its parameters in T2DM patients according to the IDF MetS definition.
Ezenwaka et al.’s findings were consistent with those from the current study in which the
prevalence rate of abdominal obesity was high among the Tobagonian population and
was associated with elevated fasting blood sugar regardless of gender.
In the current study, gender played a role in the relationship between abnormal
obesity measures and elevated blood pressure (57.1% of men and 50.9% of women).
Pearson’s chi-square test showed the relationship was statistically significant in
abnormal obesity measures and elevated blood pressure for women but not for men.
However, the direction of the relationship was very weak. Barbosa et al. (2011) used
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obesity measures of WC and found that females with abnormal WC had a higher
chance of developing hypertension according to several obesity measures with
hypertension among older adults in Barbados and Cuba. In the current study, although
women had a much higher rate of having abnormal obesity measures and elevated
fasting blood than men (65.8 % and 58.6%, respectively), the relationships were not
statistically significant.
Relationship of Metabolic Risk Factors and Covariates
The SET framework provided a theoretical perspective of the increased
prevalence of obesity and metabolic risk factors (see Ryu et al., 2017). The multilayered
structure of the framework encompasses many factors that have behavior influences
(Solomon, 2015). According to Panizzon et al. (2015), environmental impact including
socioeconomic and behavioral influences were causative agents for an increase in
prevalence of MetS. The T&T MOH (2015) acknowledged that behavioral influences
such as smoking, alcohol consumption, unhealthy diet, and low physical activities are
modifiable factors. Bergens et al. (2020) hypothesized that these behavior risks factors
are significant elements with a potential to impact obesity and metabolic risk. Ensenyat et
al. (2017) further emphasized that behavior risk factors are modifiable and can reverse
the prevalence of obesity and metabolic risk factors.
I used the SET in the current study to recognize factors that influence obesity and
metabolic risk factors and factors that affect behavior choices (see Ryu et al., 2017;
Solomon, 2015). In contrast to Bergens et al. (2020) and Ensenyat et al. (2017), I found
insufficient evidence to support behavior risk factors (sugary drink consumption, salt
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intake, and physical activity) having an impact on metabolic risk factors. Nonetheless,
focus on these behavior risk factors are detrimental in social changes through
preventative strategies as they encourage behavior changes and impact positively on
health.
Limitations of the Study
Although the results of the study yielded interesting conclusions, there were
several limitations. One of the major limitations was the delay in the data collection
process due to the coronavirus pandemic. Most workplaces had strict COVID-19 rules
that included social distancing, sanitizing guidelines, and restrictions on the number of
people allowed at a workplace. As a result, the data collection process took a longer time.
Another limitation was related to the sample size and sample population used in the
study. Initially, I proposed to investigate a sample population of 264 participants, but I
was able to recruit a larger population of 270 adult Tobagonians for the study. Despite the
larger sample size, I examined Tobagonians 18 to 60 years of age and working in
government institutions, which made the findings difficult to generalize to other
populations or geographic locations.
There were limitation in the study from data collection instrument. The instrument
contains personal information about the participants, including present health-related
perceptions, behaviors risk factors and demographic information adapted from the
BRFSS (Garmon Bibb et al., 2014; Ward et al., 2016). With the cultural disposition that
exists within the Tobago space, barriers such as disease perception and acceptance, and
fear of stigmatization, allowed participants to withhold pertinent information (Brathwaite
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& Lemonde, 2015; Roopnarinesingh et al., 2015). Some participants may not be truthful
to disclose personal information that warrants them to be part of the study. There may be
shortcomings in the interpretation of the findings, which may provide misclassification in
identifying an accurate prevalence rate of metabolic risks. Ethical issues such as privacy,
confidentiality and informed consent were addressed to minimize such limitations.
Finally, the study format was cross-sectional in nature. Consequently, causal
inferences may be difficult to determine the association between abnormal obesity
measures and metabolic risk factors, because cross-sectional studies prohibit inferences
about cause-effect relationships (Lee & Kim, 2014; Setia, 2016).
Recommendations for Action
Given the result of the research, a number of recommendations are put forward.
Regardless of, the mixed findings which contradict the existing body of evidence along
with this study hypothesis, the result of this study provides valuable and current data on
the prevalence of obesity measures with metabolic risk factors among the Tobago
working class population, especially since data highlighting this problem was limited and
outdated for this population. From the literature, it is clear that metabolic risk factors not
only affect adults, but also young children and adolescents; therefore, it is beneficial that
an investigation must be carried out on this sub-group to recognize the extent of the
problem among Tobago’s future generation. An extensive population-based survey may
be lucrative to monitor and evaluate risk factors from a national level.
This study consisted of a small sample size of 270 Tobagonians within the age
group of 18 to 60 years. The results for this small sample size may underrepresent the

111
general population, and the true measure of plethora for the prevalence of metabolic risk
factors with abnormal obesity measures. Supplementary researchers should seek to
increase the sampling population and to have a more representative sample which will
incorporate samples not only working in the public sector, but also persons working in
the private sectors. It should include a larger geographical scope because the findings
were limited only to Tobagonians within the age group of 18 to 60 years.
The socioecological perspective is vital to provide a theoretical understanding of
the increased prevalence of obesity and metabolic risk factors (Podgurski, 2016; Ryu et
al., 2017). It underpins many factors that affects behavior choices, which includes
physical, biological, social and cultural characteristics of the individuals from an
environmental and institutional perspective (Solomon, 2015). However, in
recommending a population-based intervention, the application of the socioecological
framework will be pivotal for planning, implementing and evaluating health promotion
and awareness activities, in order to reduce the prevalence of obesity and metabolic risk
factors.
Based on what was presented in the existing literature, factors such as culture,
ethnicity and geographical variances were identified as key contributors to the association
between anthropometric indexes and metabolic risk factors (Barbosa et al., 2011).
However, these factors were excluded within the study. Having a better perspective on
the role of culture in the development of obesity and metabolic risk factors may be
detrimental in providing a theoretical understanding which can be geared toward positive
social changes.
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Implications for Social Change
The recognition of the various obesity measures which impacts metabolic risk
factors can serve as a valuable reference guide in clinical decision-making and to provide
a higher standard of care to the Tobago population. Although these measures were not
determinants of metabolic risk factors within this present study, based on the literature
review presented in Chapter 2, the application of WC, BMI, and WHR can be valuable
tools for clinical assessments and health surveillance. These should be integral into
prevention, management, and control strategies of metabolic risk factors. These methods
are easy, reputable and cost-effective that should be mandatory as part of any training
protocol to improve clinician’s knowledge and competencies on metabolic risk and
obesity.
Understanding the extent of the problem may help public health practitioners and
policymakers to channel a considerable number of resources into awareness and
prevention strategies. These approaches should support and promote health education and
promotion initiatives designed to curb the emerging trend of obesity and metabolic risk
factors. This research can contribute to positive social change since it is geared towards
the improvement of existing health standards among Tobagonians. Especially since MetS
and obesity were found to have a negative impact not only on the country’s healthcare
expenditure, but significantly on life expectancy rate of the country as it aids further
health issues or comorbidities (Jarolimova et al., 2013).
Prior to this study, it seems that there was little or no evidence-based research
conducted on the topic of obesity and metabolic risk factors, solely within the Tobago

113
population. Ezenwaka et al. (2007) and Ramsaran and Maharaj (2017) used samples for
both islands of T&T, in their investigation concerning metabolic risk factors. However,
apart from the authors using a very small sample size of the Tobago population in these
studies, the authors consolidated both island T&T to make inferences which were likely
to cause biases, since there is diversity within the cultural fabric of both islands. This
study addresses the limitations from within the literature, by solely investigating
Tobagonians and by using a larger sampling size which enhances the trustworthiness and
precision of the study.
Conclusion of the Study
I implemented this quantitative study to examine the prevalence of metabolic risk
factors amongst the Tobago adult population, and also determined whether there is a
correlation between abnormal obesity measures and metabolic risk factors among Tobago
adults, within the age group of 18 to 60 years. Apart from the supporting evidence
available in the literature review, there is a noticeable prevalence of obesity and
metabolic risk factors recognized among the Tobago population, in this study. While
there are noteworthy limitations, the current study provides an update and an addition to
the scanty knowledge available regarding the prevalence of metabolic risk factors within
the Tobago diaspora. Despite the mixed finding generated within this study, existing
evidence recognized that measurements such as WC, BMI, and WHR are simple and
beneficial indices which are often used to draw inferences on the prevalence of weightrelated health risks. For this present study, although relationships were found between
WC, WHR, and BMI and metabolic risk factors, the effect was quite small. These
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findings recognize the significance of gender-specifics, in which WC and BMI have a
small effect on blood pressure range ≥ 130/85 mm Hg for female and male respectively.
Even as the assessment of the hypotheses shows a significant prevalence of
abnormal obesity measures for both metabolic risk factors, it is recognizable that the
prevalence rate for elevated fasting blood sugar is slightly higher than that of elevated
blood pressure. Nonetheless, these observations should be an eye-opener for public health
clinicians and policymakers, because risk factors are above a 50% prevalence margin.
These should spark genuine concerns, since heart disease is the number one health issue
that is responsible for 25% of deaths amongst the T&T population, followed by diabetes
which accounts for14% of deaths (MOH, 2017).
Identifying the extent of this problem can assist public health practitioners and
policymakers to use a holistic approach and channel resources into health awareness and
prevention initiatives. Although this present study found insufficient evidence to support
that behavior risk factors (sugary drink consumption, salt intake, and physical activity)
have an impact on metabolic risk factors, still preventative strategies should support and
promote health education and promotion initiatives which factors to promote behavior
changes. This will help to reduce the emerging trend of obesity and metabolic risk
factors, thus, targeting both sexes at different stages in life.
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Appendix A: Research Instrument/Questionnaire
Section 1: Demographics
1,1 Indicate sex of respondent.
1

Male

2

Female

1.2 What is your age?
_____age in years
7 7 Don’t know / Not sure
9 9 Refused

1.3 Which one or more of the following would you say is your race?
10 White
20 Black
30 Indian
40 Chinese
50 Mixed- race

1.4 Are you…?
1 Married
2 Divorced
3 Widowed
4 Separated
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4 Never married
1.5 What is the highest level or year of school you completed?
1 kindergarten
2 Elementary/ Primary school
3 Secondary school
4 Technical/Vocational school
6 Colleague/University
7 Post graduate degree
9 9 Refused
1.6 Is your monthly income from all sources?
1 < $1,000
2 $1,000 - $2,999
3 $3,000 - $4,999
4 $5,000 - $6,999
5 $7,000 - $9,999
6 ≥ $10,000
77 Don’t Know
9 9 Refused
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Section 2: Obesity Measures
2.1 About how much do you weigh without shoes?
_ _ _ _ Weight (pounds/kilograms)
7 7 Don’t know / Not sure
9 9 Refused

2.2 About how tall are you without shoes?
_ _ / _ _ Height (centimeters)
7 7/ 7 7 Don’t know
9 9/ 9 9 Refused
2.3 During the health screening exercise in your workplace, about how much was your
waist measurement in centimeters?
_ _ _ _ Waist (centimeters)
7 7Don’t know / Not sure
9 9 Refused
2.4 During the health screening exercise in your workplace, about how much was your
hip measurement?
_ _ _ _ Hip (centimeters)
7 7 Don’t know / Not sure
9 9 Refused
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Section 3: Metabolic Risk Awareness
3.1 During the health screening exercise in your workplace, have you been told by health
professional that you have high blood pressure?
1 Yes
2 No
77 Don’t know / Not sure
9.9 Refused
3.2 During the health screening exercise in your workplace, about how much was your
blood pressure measurement?
_ _ _ _ mmHg
7 7 Don’t know / Not sure
9 9 Refused
3.3 During the health screening in your workplace, have you been told by health
professional that you have high blood sugar levels?
1 Yes
2 No
7 7 Don’t know / Not sure
9 9 Refused
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3.4 During the health screening exercise in your workplace, about how much was your
blood sugar measurement?
_ _ _ _ mg/dl
7 7 Don’t know / Not sure
9 9 Refused
Section 4: Behavior Risk Factors
4.1 Do you now smoke cigarettes every day, some days, or not at all?
1 Every day
2 Some days
3 Not at all
7 7 Don’t know / Not sure
9 9 Refused
4.2 During the past 12 months, have you stopped smoking for one day or longer because
you were trying to quit smoking?
1 Yes
2 No
7 7 Don’t know / Not sure
9 9 Refused
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4.3 During the past 30 days, how many days per week or per month did you have at least
one drink of any alcoholic beverage such as, beer, wine, a malt beverage or liquor,
whiskey, gin, vodka?
1 _ _ Days per week 2
2 _ _ Days in past 30 days
3_ _No drinks in past 30 days
7 7 Don’t know / Not sure
9 9 Refused
4.3 Are you currently watching or reducing your sodium or salt intake?
1 Yes
2 No
7 7 Don’t know/not sure
9 9 Refused
4.4 Has a doctor or other health professional ever advised you to reduce sodium or salt
intake?
1 Yes
2 No
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4.5 During the past 30 days, how often did you drink sugar-sweetened fruit drinks (such
as Kool-aid and lemonade), sweet tea, and sports or energy drinks (such as Gatorade and
Red Bull)? Do not include 100% fruit juice, diet drinks, or artificially sweetened drinks.
1 _ _ Times per day
2 _ _ Times per week
3 _ _ Times per month
4._ _None
7 7 Don’t know / Not sure
9 9 Refused
4.6 During the past month, how many times per day, week or month did you drink 100%
PURE fruit juices? Do not include fruit-flavored drinks with added sugar or fruit juice
you made at home and added sugar to. Only include 100% juice.
1 _ _ Per day
2 _ _ Per week
3 _ _ Per month
4 _ _ Never
7 7 Don’t know / Not sure
9 9 Refused
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4.7 During the past month, not counting juice, how many times per day, week, or month
did you eat fruit? Count fresh, frozen, or canned fruit
1 _ _ Per day
2 _ _ Per week
3 _ _ Per month
4 _ _Never
7 7 Don’t know / Not sure
9 9 Refused
4.8 During the past month, how many times per day, week, or month did you eat dark
green vegetables, yellow ones and other ones forexample patchoi, dasheen bush, badji
(any dark leafy greens), bodi, broccoli, carrots, squash, egg plants, cabbage, tomatoes,
cauliflower
1 _ _ Per day
2 _ _ Per week
3 _ _ Per month
4 _ _ Never
7 7 Don’t know / Not sure
9 9 Refused
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4.9 During the past month, other than your regular job, did you participate in any physical
activities or exercises such as running, basketball, netball, swimming, gardening, or
walking for exercise?
1 Yes
2 No
7.7 Don’t know / Not sure
9 9 Refused
4.10 What type of physical activity or exercise did you spend the most time doing during
the past month?
_ _ (Specify)
7 7 Don’t know / Not Sure
9 9 Refused
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